BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 611987 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H29F3N2O3/c1-18-19(13-14-26(35)36)7-4-8-25(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(17-33-16-23)29(30,31)32/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,34,37)(H,35,36) BQUFVNCYDJQTBE-UHFFFAOYSA-N 314816 (R/S) 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 1 Prostaglandin G/H synthase 2 Human 14.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314816&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417157 383541639 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611988 Cc1c(CCC(O)=O)cccc1NC(=O)[C@H](C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F |r| InChI=1S/C29H29F3N2O3/c1-18-19(13-14-26(35)36)7-4-8-25(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(17-33-16-23)29(30,31)32/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,34,37)(H,35,36) BQUFVNCYDJQTBE-UHFFFAOYSA-N 314817 (−) (R) 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 2 Prostaglandin G/H synthase 2 Human 20.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314817&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416986 383541640 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611989 Cc1c(CCC(O)=O)cccc1NC(=O)[C@@H](C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F |r| InChI=1S/C29H29F3N2O3/c1-18-19(13-14-26(35)36)7-4-8-25(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(17-33-16-23)29(30,31)32/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,34,37)(H,35,36) BQUFVNCYDJQTBE-UHFFFAOYSA-N 314818 (+) (S) 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 3 Prostaglandin G/H synthase 2 Human 198 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314818&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417254 383541641 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611990 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1ccc(nc1)C(F)(F)F InChI=1S/C29H29F3N2O3/c1-18-19(14-16-26(35)36)7-4-8-24(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-13-15-25(33-17-23)29(30,31)32/h4,7-13,15,17,21,27H,2-3,5-6,14,16H2,1H3,(H,34,37)(H,35,36) RYDVHWGMMHCVIA-UHFFFAOYSA-N 314819 (R/S) 3-{3-[(Cyclopentyl{4-[6-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 5::US10172814, Example 4 Prostaglandin G/H synthase 2 Human 1320 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314819&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417032 383541642 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611991 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1ccc(nc1)C(F)(F)F InChI=1S/C29H29F3N2O3/c1-18-19(14-16-26(35)36)7-4-8-24(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-13-15-25(33-17-23)29(30,31)32/h4,7-13,15,17,21,27H,2-3,5-6,14,16H2,1H3,(H,34,37)(H,35,36) RYDVHWGMMHCVIA-UHFFFAOYSA-N 314819 (R/S) 3-{3-[(Cyclopentyl{4-[6-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 5::US10172814, Example 4 Prostaglandin G/H synthase 2 Human 795 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314819&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417032 383541642 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611992 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(F)c1 InChI=1S/C28H29FN2O3/c1-18-19(13-14-26(32)33)7-4-8-25(18)31-28(34)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(29)17-30-16-23/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,31,34)(H,32,33) BQZCIPSDARTPJF-UHFFFAOYSA-N 314822 (R/S) 3-[3-({Cyclopentyl[4-(5-fluoropyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 6 Prostaglandin G/H synthase 2 Human 162 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314822&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426879 383541644 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611993 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1ccc(nc1)C#N InChI=1S/C29H29N3O3/c1-19-20(14-16-27(33)34)7-4-8-26(19)32-29(35)28(22-5-2-3-6-22)23-11-9-21(10-12-23)24-13-15-25(17-30)31-18-24/h4,7-13,15,18,22,28H,2-3,5-6,14,16H2,1H3,(H,32,35)(H,33,34) DHJJJVAMXQKMBR-UHFFFAOYSA-N 314823 (R/S) 3-[3-({[4-(6-Cyanopyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 7 Prostaglandin G/H synthase 2 Human 3160 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314823&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417341 383541645 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611994 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H34N2O4/c1-3-36-26-17-25(18-31-19-26)22-11-13-24(14-12-22)29(23-7-4-5-8-23)30(35)32-27-10-6-9-21(20(27)2)15-16-28(33)34/h6,9-14,17-19,23,29H,3-5,7-8,15-16H2,1-2H3,(H,32,35)(H,33,34) ZEYBKQCMDLYKBH-UHFFFAOYSA-N 314824 (R/S) 3-[3-({Cyclopentyl[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 8 Prostaglandin G/H synthase 2 Human 160 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314824&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426801 383541646 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611995 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(C)(C)O InChI=1S/C31H36N2O4/c1-20-21(15-16-28(34)35)9-6-10-27(20)33-30(36)29(23-7-4-5-8-23)24-13-11-22(12-14-24)25-17-26(19-32-18-25)31(2,3)37/h6,9-14,17-19,23,29,37H,4-5,7-8,15-16H2,1-3H3,(H,33,36)(H,34,35) KOTQLUDYIJFJHT-UHFFFAOYSA-N 314825 (R/S) 3-{3-[(Cyclopentyl{4-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 9 Prostaglandin G/H synthase 2 Human 3560 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314825 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314825&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426854 383541647 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611996 COCc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H34N2O4/c1-20-22(14-15-28(33)34)8-5-9-27(20)32-30(35)29(24-6-3-4-7-24)25-12-10-23(11-13-25)26-16-21(19-36-2)17-31-18-26/h5,8-13,16-18,24,29H,3-4,6-7,14-15,19H2,1-2H3,(H,32,35)(H,33,34) MBNWVFOQUTWRQT-UHFFFAOYSA-N 314826 (R/S) 3-{3-[(Cyclopentyl{4-[5-(methoxymethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 10 Prostaglandin G/H synthase 2 Human 470 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314826 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314826&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426885 383541648 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611997 COc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O4/c1-19-20(14-15-27(32)33)8-5-9-26(19)31-29(34)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(35-2)18-30-17-24/h5,8-13,16-18,22,28H,3-4,6-7,14-15H2,1-2H3,(H,31,34)(H,32,33) OYQZHTOHAMOKKQ-UHFFFAOYSA-N 314827 (R/S) 3-[3-({Cyclopentyl[4-(5-methoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 11 Prostaglandin G/H synthase 2 Human 341 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314827 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314827&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417080 383541649 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611998 Cc1ccncc1-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O3/c1-19-16-17-30-18-25(19)22-10-12-24(13-11-22)28(23-6-3-4-7-23)29(34)31-26-9-5-8-21(20(26)2)14-15-27(32)33/h5,8-13,16-18,23,28H,3-4,6-7,14-15H2,1-2H3,(H,31,34)(H,32,33) MDTQSLYCRROGCG-UHFFFAOYSA-N 314828 (R/S) 3-[3-({Cyclopentyl[4-(4-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 12 Prostaglandin G/H synthase 2 Human 579 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314828 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314828&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426899 383541650 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 611999 CCc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H34N2O3/c1-3-21-17-26(19-31-18-21)23-11-13-25(14-12-23)29(24-7-4-5-8-24)30(35)32-27-10-6-9-22(20(27)2)15-16-28(33)34/h6,9-14,17-19,24,29H,3-5,7-8,15-16H2,1-2H3,(H,32,35)(H,33,34) ADBXMSUPMFCBGS-UHFFFAOYSA-N 314829 (R/S) 3-[3-({Cyclopentyl[4-(5-ethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 13 Prostaglandin G/H synthase 2 Human 78.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314829 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314829&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426898 383541651 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612000 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C1CC1 InChI=1S/C31H34N2O3/c1-20-21(15-16-29(34)35)7-4-8-28(20)33-31(36)30(24-5-2-3-6-24)25-13-11-23(12-14-25)27-17-26(18-32-19-27)22-9-10-22/h4,7-8,11-14,17-19,22,24,30H,2-3,5-6,9-10,15-16H2,1H3,(H,33,36)(H,34,35) YCVTYVYKSXADCO-UHFFFAOYSA-N 314830 (R/S) 3-[3-({Cyclopentyl[4-(5-cyclopropylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 14 Prostaglandin G/H synthase 2 Human 115 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314830 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314830&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417178 383541652 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612001 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(OC2CCOCC2)c1 InChI=1S/C33H38N2O5/c1-22-23(13-14-31(36)37)7-4-8-30(22)35-33(38)32(25-5-2-3-6-25)26-11-9-24(10-12-26)27-19-29(21-34-20-27)40-28-15-17-39-18-16-28/h4,7-12,19-21,25,28,32H,2-3,5-6,13-18H2,1H3,(H,35,38)(H,36,37) FVKGCAKLTGGWRJ-UHFFFAOYSA-N 314831 (R/S) 3-{3-[(Cyclopentyl{4-[5-(tetrahydro-2H-pyran-4-yloxy)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 15 Prostaglandin G/H synthase 2 Human 114 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314831 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314831&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426955 383541653 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612002 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C28H29ClN2O3/c1-18-19(13-14-26(32)33)7-4-8-25(18)31-28(34)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(29)17-30-16-23/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,31,34)(H,32,33) LUWOXMQWGOWQSN-UHFFFAOYSA-N 314832 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 16 Prostaglandin G/H synthase 2 Human 59.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314832 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314832&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426856 383541654 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612003 Cc1c(CCC(O)=O)cccc1NC(=O)[C@H](C1CCCC1)c1ccc(cc1)-c1cncc(Cl)c1 |r| InChI=1S/C28H29ClN2O3/c1-18-19(13-14-26(32)33)7-4-8-25(18)31-28(34)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(29)17-30-16-23/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,31,34)(H,32,33) LUWOXMQWGOWQSN-UHFFFAOYSA-N 314833 (−) (R) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 17 Prostaglandin G/H synthase 2 Human 35.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314833&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417226 383541655 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612004 COc1ccc(cn1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O4/c1-19-20(15-17-27(32)33)8-5-9-25(19)31-29(34)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-14-16-26(35-2)30-18-24/h5,8-14,16,18,22,28H,3-4,6-7,15,17H2,1-2H3,(H,31,34)(H,32,33) HASAMKFJCPRNKM-UHFFFAOYSA-N 314834 (R/S) 3-[3- ({Cyclopentyl[4-(6- methoxypyridin-3-yl)- phenyl]acetyl}amino)-2- methylphenyl]propanoic acid::US10172814, Example 18 Prostaglandin G/H synthase 2 Human 236 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314834 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314834&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426853 383541656 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612005 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1ccc(F)nc1 InChI=1S/C28H29FN2O3/c1-18-19(14-16-26(32)33)7-4-8-24(18)31-28(34)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-13-15-25(29)30-17-23/h4,7-13,15,17,21,27H,2-3,5-6,14,16H2,1H3,(H,31,34)(H,32,33) KLIOSVDMRNWIKJ-UHFFFAOYSA-N 314835 (R/S) 3-[3- ({Cyclopentyl[4-(6- fluoropyridin-3-yl)- phenyl]acetyl}amino)-2- methylphenyl]propanoic acid::US10172814, Example 19 Prostaglandin G/H synthase 2 Human 552 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314835&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426857 383541657 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612006 COc1ncccc1-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O4/c1-19-20(16-17-26(32)33)9-5-11-25(19)31-28(34)27(22-7-3-4-8-22)23-14-12-21(13-15-23)24-10-6-18-30-29(24)35-2/h5-6,9-15,18,22,27H,3-4,7-8,16-17H2,1-2H3,(H,31,34)(H,32,33) RWYQXYMBOYYLEN-UHFFFAOYSA-N 314836 (R/S) 3-[3- ({Cyclopentyl[4-(2- methoxypyridin-3-yl)- phenyl]acetyl}amino)-2- methylphenyl]propanoic acid::US10172814, Example 20 Prostaglandin G/H synthase 2 Human 2550 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314836 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314836&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426855 383541658 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612007 Cc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O3/c1-19-16-25(18-30-17-19)22-10-12-24(13-11-22)28(23-6-3-4-7-23)29(34)31-26-9-5-8-21(20(26)2)14-15-27(32)33/h5,8-13,16-18,23,28H,3-4,6-7,14-15H2,1-2H3,(H,31,34)(H,32,33) YZJMHVHSNRSMQJ-UHFFFAOYSA-N 314837 (R/S) 3-[3- ({Cyclopentyl[4-(5- methylpyridin-3-yl)- phenyl]acetyl}amino)-2- methylphenyl]propanoic acid::US10172814, Example 21 Prostaglandin G/H synthase 2 Human 161 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314837 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314837&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417260 383541659 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612008 Cc1ccc(cn1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O3/c1-19-10-11-25(18-30-19)22-12-14-24(15-13-22)28(23-6-3-4-7-23)29(34)31-26-9-5-8-21(20(26)2)16-17-27(32)33/h5,8-15,18,23,28H,3-4,6-7,16-17H2,1-2H3,(H,31,34)(H,32,33) DMZUAELZDQPIBP-UHFFFAOYSA-N 314838 (R/S) 3-[3- ({Cyclopentyl[4-(6- methylpyridin-3-yl)- phenyl]acetyl}amino)-2- methylphenyl]propanoic acid::US10172814, Example 22 Prostaglandin G/H synthase 2 Human 299 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314838 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314838&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426906 383541660 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612009 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cccnc1F InChI=1S/C28H29FN2O3/c1-18-19(15-16-25(32)33)8-4-10-24(18)31-28(34)26(21-6-2-3-7-21)22-13-11-20(12-14-22)23-9-5-17-30-27(23)29/h4-5,8-14,17,21,26H,2-3,6-7,15-16H2,1H3,(H,31,34)(H,32,33) JKPMMSGXLYCCLT-UHFFFAOYSA-N 314839 (R/S) 3-[3- ({cyclopentyl[4-(2-fluoro- pyridin-3-yl)-phenyl]- acetyl}amino)-2-methyl- phenyl]propanoic acid::US10172814, Example 23 Prostaglandin G/H synthase 2 Human 5260 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314839 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314839&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426907 383541661 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612010 Cc1ncc(cc1Cl)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H31ClN2O3/c1-18-20(14-15-27(33)34)8-5-9-26(18)32-29(35)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(30)19(2)31-17-24/h5,8-13,16-17,22,28H,3-4,6-7,14-15H2,1-2H3,(H,32,35)(H,33,34) LFOCEOFBNPVEJE-UHFFFAOYSA-N 314841 (R/S) 3-[3-({[4-(5-Chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 24 Prostaglandin G/H synthase 2 Human 22.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314841 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314841&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417025 383541663 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612011 Cc1ncc(cc1Cl)-c1ccc(cc1)[C@H](C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C |r| InChI=1S/C29H31ClN2O3/c1-18-20(14-15-27(33)34)8-5-9-26(18)32-29(35)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(30)19(2)31-17-24/h5,8-13,16-17,22,28H,3-4,6-7,14-15H2,1-2H3,(H,32,35)(H,33,34) LFOCEOFBNPVEJE-UHFFFAOYSA-N 314842 (+) (S) 3-[3-({[4-(5-Chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 25 Prostaglandin G/H synthase 2 Human 2250 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314842 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314842&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417049 383541664 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612012 Cc1ncc(cc1Cl)-c1ccc(cc1)[C@@H](C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C |r| InChI=1S/C29H31ClN2O3/c1-18-20(14-15-27(33)34)8-5-9-26(18)32-29(35)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(30)19(2)31-17-24/h5,8-13,16-17,22,28H,3-4,6-7,14-15H2,1-2H3,(H,32,35)(H,33,34) LFOCEOFBNPVEJE-UHFFFAOYSA-N 314843 (−) (R) 3-[3-({[4-(5-Chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 26 Prostaglandin G/H synthase 2 Human 15.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314843&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417105 383541665 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612013 Cc1cc(cnc1C)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H34N2O3/c1-19-17-26(18-31-21(19)3)23-11-13-25(14-12-23)29(24-7-4-5-8-24)30(35)32-27-10-6-9-22(20(27)2)15-16-28(33)34/h6,9-14,17-18,24,29H,4-5,7-8,15-16H2,1-3H3,(H,32,35)(H,33,34) BNJWNHYPOPYQIR-UHFFFAOYSA-N 314844 (R/S) 3-[3-({Cyclopentyl[4-(5,6-dimethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 27 Prostaglandin G/H synthase 2 Human 90.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314844&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426846 383541666 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612014 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(OC(F)F)c1 InChI=1S/C29H30F2N2O4/c1-18-19(13-14-26(34)35)7-4-8-25(18)33-28(36)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(17-32-16-23)37-29(30)31/h4,7-12,15-17,21,27,29H,2-3,5-6,13-14H2,1H3,(H,33,36)(H,34,35) ZHJUHIJQNZYCGP-UHFFFAOYSA-N 314845 (R/S) 3-{3-[(Cyclopentyl{4-[5-(difluoromethoxy)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 28 Prostaglandin G/H synthase 2 Human 380 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314845&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426889 383541667 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612015 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)F InChI=1S/C29H30F2N2O3/c1-18-19(13-14-26(34)35)7-4-8-25(18)33-29(36)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(28(30)31)17-32-16-23/h4,7-12,15-17,21,27-28H,2-3,5-6,13-14H2,1H3,(H,33,36)(H,34,35) IZJKQFIBOBWKHL-UHFFFAOYSA-N 314846 (R/S) 3-{3-[(Cyclopentyl{4-[5-(difluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 29 Prostaglandin G/H synthase 2 Human 78.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314846&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426958 383541668 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612016 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(CF)c1 InChI=1S/C29H31FN2O3/c1-19-21(13-14-27(33)34)7-4-8-26(19)32-29(35)28(23-5-2-3-6-23)24-11-9-22(10-12-24)25-15-20(16-30)17-31-18-25/h4,7-12,15,17-18,23,28H,2-3,5-6,13-14,16H2,1H3,(H,32,35)(H,33,34) RLHUVEMVZGASTE-UHFFFAOYSA-N 314848 (R/S) 3-{3-[(Cyclopentyl{4-[5-(fluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 30 Prostaglandin G/H synthase 2 Human 188 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314848&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426805 383541670 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612017 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C26H25ClN2O3/c1-16-17(11-12-24(30)31)3-2-4-23(16)29-26(32)25(20-9-10-20)19-7-5-18(6-8-19)21-13-22(27)15-28-14-21/h2-8,13-15,20,25H,9-12H2,1H3,(H,29,32)(H,30,31) HXEPQIRPNXEGTF-UHFFFAOYSA-N 314849 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopropyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 31 Prostaglandin G/H synthase 2 Human 443 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314849&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417224 383541671 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612018 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C27H25F3N2O3/c1-16-17(11-12-24(33)34)3-2-4-23(16)32-26(35)25(20-9-10-20)19-7-5-18(6-8-19)21-13-22(15-31-14-21)27(28,29)30/h2-8,13-15,20,25H,9-12H2,1H3,(H,32,35)(H,33,34) LZMQTYJCNOSLHW-UHFFFAOYSA-N 314850 (R/S) 3-{3-[(Cyclopropyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 32 Prostaglandin G/H synthase 2 Human 470 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314850&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417164 383541672 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612019 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)cccc1OCC(O)=O InChI=1S/C28H27F3N2O4/c1-17-23(7-4-8-24(17)37-16-25(34)35)33-27(36)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(15-32-14-21)28(29,30)31/h4,7-15,19,26H,2-3,5-6,16H2,1H3,(H,33,36)(H,34,35) VYEHJGYGORTRDD-UHFFFAOYSA-N 314851 (R/S) {3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenoxy}acetic acid::US10172814, Example 33 Prostaglandin G/H synthase 2 Human 14.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314851&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417211 383541673 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612020 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)cccc1OCC(O)=O InChI=1S/C28H27F3N2O4/c1-17-23(7-4-8-24(17)37-16-25(34)35)33-27(36)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(15-32-14-21)28(29,30)31/h4,7-15,19,26H,2-3,5-6,16H2,1H3,(H,33,36)(H,34,35) VYEHJGYGORTRDD-UHFFFAOYSA-N 314852 (−) {3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenoxy}acetic acid::US10172814, Example 34 Prostaglandin G/H synthase 2 Human 9.85 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314852&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417211 383541674 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612021 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)cccc1OCC(O)=O InChI=1S/C28H27F3N2O4/c1-17-23(7-4-8-24(17)37-16-25(34)35)33-27(36)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(15-32-14-21)28(29,30)31/h4,7-15,19,26H,2-3,5-6,16H2,1H3,(H,33,36)(H,34,35) VYEHJGYGORTRDD-UHFFFAOYSA-N 314853 (+) {3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenoxy}acetic acid::US10172814, Example 35 Prostaglandin G/H synthase 2 Human 3730 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314853&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417211 383541675 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612022 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)cccc1OCC(O)=O InChI=1S/C27H27ClN2O4/c1-17-23(7-4-8-24(17)34-16-25(31)32)30-27(33)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(28)15-29-14-21/h4,7-15,19,26H,2-3,5-6,16H2,1H3,(H,30,33)(H,31,32) GMALHSWNLMGJLT-UHFFFAOYSA-N 314854 US10172814, Example 37::(R/S) [3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenoxy]acetic acid::US10172814, Example 36 Prostaglandin G/H synthase 2 Human 32.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314854&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417086 383541676 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612023 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)cccc1OCC(O)=O InChI=1S/C27H27ClN2O4/c1-17-23(7-4-8-24(17)34-16-25(31)32)30-27(33)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(28)15-29-14-21/h4,7-15,19,26H,2-3,5-6,16H2,1H3,(H,30,33)(H,31,32) GMALHSWNLMGJLT-UHFFFAOYSA-N 314854 US10172814, Example 37::(R/S) [3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenoxy]acetic acid::US10172814, Example 36 Prostaglandin G/H synthase 2 Human 14.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314854&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417086 383541676 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612024 COc1ccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c(C)c1CCC(O)=O InChI=1S/C29H31ClN2O4/c1-18-24(11-14-27(33)34)26(36-2)13-12-25(18)32-29(35)28(20-5-3-4-6-20)21-9-7-19(8-10-21)22-15-23(30)17-31-16-22/h7-10,12-13,15-17,20,28H,3-6,11,14H2,1-2H3,(H,32,35)(H,33,34) RWXYPGOFFKXNHR-UHFFFAOYSA-N 314856 US10172814, Example 39::(R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-6-methoxy-2-methylphenyl]propanoic acid::US10172814, Example 38 Prostaglandin G/H synthase 2 Human 46.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314856&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417054 383541677 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612025 COc1ccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c(C)c1CCC(O)=O InChI=1S/C29H31ClN2O4/c1-18-24(11-14-27(33)34)26(36-2)13-12-25(18)32-29(35)28(20-5-3-4-6-20)21-9-7-19(8-10-21)22-15-23(30)17-31-16-22/h7-10,12-13,15-17,20,28H,3-6,11,14H2,1-2H3,(H,32,35)(H,33,34) RWXYPGOFFKXNHR-UHFFFAOYSA-N 314856 US10172814, Example 39::(R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-6-methoxy-2-methylphenyl]propanoic acid::US10172814, Example 38 Prostaglandin G/H synthase 2 Human 14.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314856&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417054 383541677 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612026 COc1ccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c(C)c1CCC(O)=O InChI=1S/C30H31F3N2O4/c1-18-24(11-14-27(36)37)26(39-2)13-12-25(18)35-29(38)28(20-5-3-4-6-20)21-9-7-19(8-10-21)22-15-23(17-34-16-22)30(31,32)33/h7-10,12-13,15-17,20,28H,3-6,11,14H2,1-2H3,(H,35,38)(H,36,37) DLPJPIYIOFIHSX-UHFFFAOYSA-N 314858 (R/S) 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-6-methoxy-2-methylphenyl}propanoic acid::US10172814, Example 40 Prostaglandin G/H synthase 2 Human 28.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314858 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314858&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426905 383541678 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612027 Cc1cc(ccc1-c1cncc(c1)C(F)(F)F)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H31F3N2O3/c1-18-14-22(10-12-25(18)23-15-24(17-34-16-23)30(31,32)33)28(21-6-3-4-7-21)29(38)35-26-9-5-8-20(19(26)2)11-13-27(36)37/h5,8-10,12,14-17,21,28H,3-4,6-7,11,13H2,1-2H3,(H,35,38)(H,36,37) RICMKGQEVPIXFQ-UHFFFAOYSA-N 314859 (R/S) 3-{3-[(Cyclopentyl{3-methyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 41 Prostaglandin G/H synthase 2 Human 19.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314859&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416990 383541679 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612028 Cc1cc(ccc1-c1cncc(Cl)c1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H31ClN2O3/c1-18-14-22(10-12-25(18)23-15-24(30)17-31-16-23)28(21-6-3-4-7-21)29(35)32-26-9-5-8-20(19(26)2)11-13-27(33)34/h5,8-10,12,14-17,21,28H,3-4,6-7,11,13H2,1-2H3,(H,32,35)(H,33,34) GAZFWMPSEBFSJH-UHFFFAOYSA-N 314862 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)-3-methylphenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 42 Prostaglandin G/H synthase 2 Human 46.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314862 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314862&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426960 383541681 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612029 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) OZUBHMWSFYBJDO-UHFFFAOYSA-N 314866 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)-3-fluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 43 Prostaglandin G/H synthase 2 Human 30.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314866 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314866&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417061 383541685 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612030 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) OZUBHMWSFYBJDO-UHFFFAOYSA-N 314867 (−) 3-[3-({[4-(5-Chloropyridin-3-yl)-3-fluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 44 Prostaglandin G/H synthase 2 Human 17.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314867&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417061 383541686 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612031 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) OZUBHMWSFYBJDO-UHFFFAOYSA-N 314868 (+) 3-[3-({[4-(5-Chloropyridin-3-yl)-3-fluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 45 Prostaglandin G/H synthase 2 Human 1680 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314868 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314868&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417061 383541687 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612032 CCOc1cncc(c1)-c1ccc(cc1F)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H33FN2O4/c1-3-37-24-15-23(17-32-18-24)25-13-11-22(16-26(25)31)29(21-7-4-5-8-21)30(36)33-27-10-6-9-20(19(27)2)12-14-28(34)35/h6,9-11,13,15-18,21,29H,3-5,7-8,12,14H2,1-2H3,(H,33,36)(H,34,35) FHGITMLXWQZCAM-UHFFFAOYSA-N 314869 (R/S) 3-[3-({Cyclopentyl[4-(5-ethoxypyridin-3-yl)-3-fluorophenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 46 Prostaglandin G/H synthase 2 Human 55.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314869 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314869&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426912 383541688 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612033 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) JAWBAVZNIXODOD-UHFFFAOYSA-N 314870 (R/S) 3-{3-[(Cyclopentyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 47 Prostaglandin G/H synthase 2 Human 15.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314870 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314870&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417117 383541689 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612034 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) JAWBAVZNIXODOD-UHFFFAOYSA-N 314872 (−) 3-{3-[(Cyclopentyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 48 Prostaglandin G/H synthase 2 Human 14.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314872 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314872&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417117 383541691 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612035 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) JAWBAVZNIXODOD-UHFFFAOYSA-N 314873 (+) 3-{3-[(Cyclopentyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 49 Prostaglandin G/H synthase 2 Human 530 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314873 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314873&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417117 383541692 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612036 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)F InChI=1S/C29H29F3N2O3/c1-17-18(10-12-26(35)36)7-4-8-25(17)34-29(37)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(28(31)32)16-33-15-21/h4,7-9,11,13-16,19,27-28H,2-3,5-6,10,12H2,1H3,(H,34,37)(H,35,36) MQDBPGDTEFZXSO-UHFFFAOYSA-N 314874 (R/S) 3-{3-[(cyclopentyl{4-[5-(difluoromethyl)pyridin-3-yl]-3-fluorophenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 50 Prostaglandin G/H synthase 2 Human 42.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314874 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314874&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 132217701 383541693 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612037 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) OZUBHMWSFYBJDO-UHFFFAOYSA-N 314875 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)-2-fluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 51 Prostaglandin G/H synthase 2 Human 69.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314875 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314875&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417061 383541694 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612038 CCOc1cncc(c1)-c1ccc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(F)c1 InChI=1S/C30H33FN2O4/c1-3-37-24-15-23(17-32-18-24)22-11-13-25(26(31)16-22)29(21-7-4-5-8-21)30(36)33-27-10-6-9-20(19(27)2)12-14-28(34)35/h6,9-11,13,15-18,21,29H,3-5,7-8,12,14H2,1-2H3,(H,33,36)(H,34,35) DXAUOAUEYYOZRZ-UHFFFAOYSA-N 314876 (R/S) 3-[3-({Cyclopentyl[4-(5-ethoxypyridin-3-yl)-2-fluorophenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 52 Prostaglandin G/H synthase 2 Human 273 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314876 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314876&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426914 383541695 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612039 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1F)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)23-11-9-20(14-24(23)30)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) UWYCVADYDGXQDL-UHFFFAOYSA-N 314877 (R/S) 3-{3-[(Cyclopentyl{2-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 53 Prostaglandin G/H synthase 2 Human 53.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314877 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314877&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426880 383541696 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612040 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H27F3N2O3/c1-17-18(12-13-25(34)35)4-3-7-24(17)33-27(36)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(16-32-15-22)28(29,30)31/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,33,36)(H,34,35) VNSSZYUUZGLDIH-UHFFFAOYSA-N 314878 (R/S) 3-{3-[(Cyclobutyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 54 Prostaglandin G/H synthase 2 Human 27.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314878 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314878&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417165 383541697 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612041 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H27F3N2O3/c1-17-18(12-13-25(34)35)4-3-7-24(17)33-27(36)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(16-32-15-22)28(29,30)31/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,33,36)(H,34,35) VNSSZYUUZGLDIH-UHFFFAOYSA-N 314879 (−) 3-{3-[(Cyclobutyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 55 Prostaglandin G/H synthase 2 Human 35.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314879&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417165 383541698 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612042 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H27F3N2O3/c1-17-18(12-13-25(34)35)4-3-7-24(17)33-27(36)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(16-32-15-22)28(29,30)31/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,33,36)(H,34,35) VNSSZYUUZGLDIH-UHFFFAOYSA-N 314882 (+) 3-{3-[(Cyclobutyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 56 Prostaglandin G/H synthase 2 Human 7520 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314882 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314882&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417165 383541701 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612043 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C27H27ClN2O3/c1-17-18(12-13-25(31)32)4-3-7-24(17)30-27(33)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(28)16-29-15-22/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,30,33)(H,31,32) CTDNBGDNFAVNQA-UHFFFAOYSA-N 314899 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclobutyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 57 Prostaglandin G/H synthase 2 Human 72.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314899 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314899&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426923 383541718 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612044 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O4/c1-3-35-25-16-24(17-30-18-25)21-10-12-23(13-11-21)28(22-7-4-8-22)29(34)31-26-9-5-6-20(19(26)2)14-15-27(32)33/h5-6,9-13,16-18,22,28H,3-4,7-8,14-15H2,1-2H3,(H,31,34)(H,32,33) YYLKPOUGGOCMAO-UHFFFAOYSA-N 314901 (R/S) 3-[3-({Cyclobutyl[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 58 Prostaglandin G/H synthase 2 Human 210 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314901 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314901&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426887 383541720 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612045 Cc1cc(cnc1C)-c1ccc(cc1)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H32N2O3/c1-18-16-25(17-30-20(18)3)22-10-12-24(13-11-22)28(23-7-4-8-23)29(34)31-26-9-5-6-21(19(26)2)14-15-27(32)33/h5-6,9-13,16-17,23,28H,4,7-8,14-15H2,1-3H3,(H,31,34)(H,32,33) NRDQTBHLWXVCDM-UHFFFAOYSA-N 314946 (R/S) 3-[3-({Cyclobutyl[4-(5,6-dimethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 59 Prostaglandin G/H synthase 2 Human 193 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314946&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426892 383541765 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612046 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(F)c1 InChI=1S/C27H27FN2O3/c1-17-18(12-13-25(31)32)4-3-7-24(17)30-27(33)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(28)16-29-15-22/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,30,33)(H,31,32) DXEUXJLQAMOOSG-UHFFFAOYSA-N 315114 (R/S) 3-[3-({Cyclobutyl[4-(5-fluoropyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 60 Prostaglandin G/H synthase 2 Human 478 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315114 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315114&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426858 383541922 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612047 Cc1ncc(cc1Cl)-c1ccc(cc1)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C28H29ClN2O3/c1-17-19(13-14-26(32)33)5-4-8-25(17)31-28(34)27(21-6-3-7-21)22-11-9-20(10-12-22)23-15-24(29)18(2)30-16-23/h4-5,8-12,15-16,21,27H,3,6-7,13-14H2,1-2H3,(H,31,34)(H,32,33) ZFLCZLYDQTUWIG-UHFFFAOYSA-N 315119 (R/S) 3-[3-({[4-(5-chloro-6-methylpyridin-3-yl)phenyl](cyclobutyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 61 Prostaglandin G/H synthase 2 Human 32.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315119&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417243 383541927 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612048 Cc1ncc(cc1F)-c1ccc(cc1)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C28H29FN2O3/c1-17-19(13-14-26(32)33)5-4-8-25(17)31-28(34)27(21-6-3-7-21)22-11-9-20(10-12-22)23-15-24(29)18(2)30-16-23/h4-5,8-12,15-16,21,27H,3,6-7,13-14H2,1-2H3,(H,31,34)(H,32,33) GXYNZNIUFPRIOJ-UHFFFAOYSA-N 315120 (R/S) 3-[3-({[4-(5-Fluoro-6-methylpyridin-3-yl)phenyl](cyclobutyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 62 Prostaglandin G/H synthase 2 Human 148 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315120 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315120&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426848 383541928 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612049 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(OC(F)F)c1 InChI=1S/C28H28F2N2O4/c1-17-18(12-13-25(33)34)4-3-7-24(17)32-27(35)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(16-31-15-22)36-28(29)30/h3-4,7-11,14-16,20,26,28H,2,5-6,12-13H2,1H3,(H,32,35)(H,33,34) FKFGGTPHFRKKOS-UHFFFAOYSA-N 315121 (R/S) 3-{3-[(Cyclobutyl{4-[5-(difluoromethoxy)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 63 Prostaglandin G/H synthase 2 Human 103 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315121&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426961 383541929 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612050 Cc1cncc(c1)-c1ccc(cc1)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C28H30N2O3/c1-18-15-24(17-29-16-18)21-9-11-23(12-10-21)27(22-6-3-7-22)28(33)30-25-8-4-5-20(19(25)2)13-14-26(31)32/h4-5,8-12,15-17,22,27H,3,6-7,13-14H2,1-2H3,(H,30,33)(H,31,32) UEKIVGXHVGDNCB-UHFFFAOYSA-N 315122 (R/S) 3-[3-({Cyclobutyl[4-(5-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 64 Prostaglandin G/H synthase 2 Human 344 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315122 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315122&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426910 383541930 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612051 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCCC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C29H31ClN2O3/c1-19-20(14-15-27(33)34)8-5-9-26(19)32-29(35)28(22-6-3-2-4-7-22)23-12-10-21(11-13-23)24-16-25(30)18-31-17-24/h5,8-13,16-18,22,28H,2-4,6-7,14-15H2,1H3,(H,32,35)(H,33,34) AMUFWNATMQNLFU-UHFFFAOYSA-N 315123 (R/S) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclohexyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 65 Prostaglandin G/H synthase 2 Human 196 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315123&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426962 383541931 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612052 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C30H31F3N2O3/c1-19-20(14-15-27(36)37)8-5-9-26(19)35-29(38)28(22-6-3-2-4-7-22)23-12-10-21(11-13-23)24-16-25(18-34-17-24)30(31,32)33/h5,8-13,16-18,22,28H,2-4,6-7,14-15H2,1H3,(H,35,38)(H,36,37) SWMJVNJTIZRMTI-UHFFFAOYSA-N 315124 (R/S) 3-{3-[(Cyclohexyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 66 Prostaglandin G/H synthase 2 Human 53.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315124&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426897 383541932 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612053 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C31H36N2O4/c1-3-37-27-18-26(19-32-20-27)23-12-14-25(15-13-23)30(24-8-5-4-6-9-24)31(36)33-28-11-7-10-22(21(28)2)16-17-29(34)35/h7,10-15,18-20,24,30H,3-6,8-9,16-17H2,1-2H3,(H,33,36)(H,34,35) SVNUAFJROXPWFA-UHFFFAOYSA-N 315125 (R/S) 3-[3-({Cyclohexyl[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 67 Prostaglandin G/H synthase 2 Human 328 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315125&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426963 383541933 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612054 CC(Cc1cccc(NC(=O)C(C2CCCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C)C(O)=O InChI=1S/C31H33F3N2O3/c1-19(30(38)39)15-24-9-6-10-27(20(24)2)36-29(37)28(22-7-4-3-5-8-22)23-13-11-21(12-14-23)25-16-26(18-35-17-25)31(32,33)34/h6,9-14,16-19,22,28H,3-5,7-8,15H2,1-2H3,(H,36,37)(H,38,39) SRFGWTPNTIVYHR-UHFFFAOYSA-N 315126 (2R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)-2-methylpropanoic acid::US10172814, Example 68 Prostaglandin G/H synthase 2 Human 46.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315126&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 132217702 383541934 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612055 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C)C(O)=O InChI=1S/C30H31F3N2O3/c1-18(29(37)38)14-23-8-5-9-26(19(23)2)35-28(36)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(17-34-16-24)30(31,32)33/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,35,36)(H,37,38) MZYVXHNMYUXVMU-UHFFFAOYSA-N 315127 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 70::US10172814, Example 71::US10172814, Example 72::US10172814, Example 69 Prostaglandin G/H synthase 2 Human 8740 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315127&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417271 383541935 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612056 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C)C(O)=O InChI=1S/C30H31F3N2O3/c1-18(29(37)38)14-23-8-5-9-26(19(23)2)35-28(36)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(17-34-16-24)30(31,32)33/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,35,36)(H,37,38) MZYVXHNMYUXVMU-UHFFFAOYSA-N 315127 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 70::US10172814, Example 71::US10172814, Example 72::US10172814, Example 69 Prostaglandin G/H synthase 2 Human 52.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315127&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417271 383541935 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612057 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C)C(O)=O InChI=1S/C30H31F3N2O3/c1-18(29(37)38)14-23-8-5-9-26(19(23)2)35-28(36)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(17-34-16-24)30(31,32)33/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,35,36)(H,37,38) MZYVXHNMYUXVMU-UHFFFAOYSA-N 315127 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 70::US10172814, Example 71::US10172814, Example 72::US10172814, Example 69 Prostaglandin G/H synthase 2 Human 15900 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315127&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417271 383541935 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612058 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C)C(O)=O InChI=1S/C30H31F3N2O3/c1-18(29(37)38)14-23-8-5-9-26(19(23)2)35-28(36)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(17-34-16-24)30(31,32)33/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,35,36)(H,37,38) MZYVXHNMYUXVMU-UHFFFAOYSA-N 315127 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 70::US10172814, Example 71::US10172814, Example 72::US10172814, Example 69 Prostaglandin G/H synthase 2 Human 71.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315127&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417271 383541935 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612059 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C)C(O)=O InChI=1S/C29H31ClN2O3/c1-18(29(34)35)14-23-8-5-9-26(19(23)2)32-28(33)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(30)17-31-16-24/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,32,33)(H,34,35) ZKESDPLLYKBBLM-UHFFFAOYSA-N 315131 US10172814, Example 74::(2R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 77::US10172814, Example 75::US10172814, Example 76::US10172814, Example 73 Prostaglandin G/H synthase 2 Human 245 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315131&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426852 383541936 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612060 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C)C(O)=O InChI=1S/C29H31ClN2O3/c1-18(29(34)35)14-23-8-5-9-26(19(23)2)32-28(33)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(30)17-31-16-24/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,32,33)(H,34,35) ZKESDPLLYKBBLM-UHFFFAOYSA-N 315131 US10172814, Example 74::(2R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 77::US10172814, Example 75::US10172814, Example 76::US10172814, Example 73 Prostaglandin G/H synthase 2 Human 0.188 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315131&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426852 383541936 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612061 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C)C(O)=O InChI=1S/C29H31ClN2O3/c1-18(29(34)35)14-23-8-5-9-26(19(23)2)32-28(33)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(30)17-31-16-24/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,32,33)(H,34,35) ZKESDPLLYKBBLM-UHFFFAOYSA-N 315131 US10172814, Example 74::(2R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 77::US10172814, Example 75::US10172814, Example 76::US10172814, Example 73 Prostaglandin G/H synthase 2 Human 71.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315131&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426852 383541936 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612062 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C)C(O)=O InChI=1S/C29H31ClN2O3/c1-18(29(34)35)14-23-8-5-9-26(19(23)2)32-28(33)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(30)17-31-16-24/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,32,33)(H,34,35) ZKESDPLLYKBBLM-UHFFFAOYSA-N 315131 US10172814, Example 74::(2R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 77::US10172814, Example 75::US10172814, Example 76::US10172814, Example 73 Prostaglandin G/H synthase 2 Human 16200 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315131&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426852 383541936 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612063 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C)C(O)=O InChI=1S/C29H31ClN2O3/c1-18(29(34)35)14-23-8-5-9-26(19(23)2)32-28(33)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(30)17-31-16-24/h5,8-13,15-18,21,27H,3-4,6-7,14H2,1-2H3,(H,32,33)(H,34,35) ZKESDPLLYKBBLM-UHFFFAOYSA-N 315131 US10172814, Example 74::(2R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 77::US10172814, Example 75::US10172814, Example 76::US10172814, Example 73 Prostaglandin G/H synthase 2 Human 127 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315131&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426852 383541936 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612064 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(C)c2)c1C)C(O)=O InChI=1S/C31H36N2O3/c1-19-16-27(18-32-22(19)4)23-12-14-25(15-13-23)29(24-8-5-6-9-24)30(34)33-28-11-7-10-26(21(28)3)17-20(2)31(35)36/h7,10-16,18,20,24,29H,5-6,8-9,17H2,1-4H3,(H,33,34)(H,35,36) UJBHMJYODKPPJL-UHFFFAOYSA-N 315136 (2R/2S)-3-[3-({(2R/2S)-2-Cyclopentyl-2-[4-(5,6-dimethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 78 Prostaglandin G/H synthase 2 Human 118 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315136&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426909 383541937 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612065 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2ccc(C)nc2)c1C)C(O)=O InChI=1S/C30H34N2O3/c1-19(30(34)35)17-25-9-6-10-27(21(25)3)32-29(33)28(23-7-4-5-8-23)24-15-13-22(14-16-24)26-12-11-20(2)31-18-26/h6,9-16,18-19,23,28H,4-5,7-8,17H2,1-3H3,(H,32,33)(H,34,35) QOCOOIKSAVIWRN-UHFFFAOYSA-N 315137 (2R/2S)-3-[3-({(2R/2S)-2-Cyclopentyl-2-[4-(6-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 79 Prostaglandin G/H synthase 2 Human 433 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315137&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426911 383541938 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612066 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(OC(F)F)c2)c1C)C(O)=O InChI=1S/C30H32F2N2O4/c1-18(29(36)37)14-23-8-5-9-26(19(23)2)34-28(35)27(21-6-3-4-7-21)22-12-10-20(11-13-22)24-15-25(17-33-16-24)38-30(31)32/h5,8-13,15-18,21,27,30H,3-4,6-7,14H2,1-2H3,(H,34,35)(H,36,37) VCHJIMHLDMORQX-UHFFFAOYSA-N 315138 (2R/2S)-3-(3-{[(2R/2S)-2-Cyclopentyl-2-{4-[5-(difluoromethoxy)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)-2-methylpropanoic acid::US10172814, Example 80 Prostaglandin G/H synthase 2 Human 88.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315138&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426861 383541939 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612067 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(C)c2)c1C)C(O)=O InChI=1S/C30H34N2O3/c1-19-15-26(18-31-17-19)22-11-13-24(14-12-22)28(23-7-4-5-8-23)29(33)32-27-10-6-9-25(21(27)3)16-20(2)30(34)35/h6,9-15,17-18,20,23,28H,4-5,7-8,16H2,1-3H3,(H,32,33)(H,34,35) RCOZORRQMHAKHL-UHFFFAOYSA-N 315139 (2R/2S)-3-[3-({(2R/2S)-2-Cyclopentyl-2-[4-(5-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 81 Prostaglandin G/H synthase 2 Human 172 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315139 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315139&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426917 383541940 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612068 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(F)c2)c1C)C(O)=O InChI=1S/C30H33FN2O3/c1-18(30(35)36)15-24-9-6-10-27(19(24)2)33-29(34)28(22-7-4-5-8-22)23-13-11-21(12-14-23)25-16-26(31)20(3)32-17-25/h6,9-14,16-18,22,28H,4-5,7-8,15H2,1-3H3,(H,33,34)(H,35,36) COJVCBPBWAKEIL-UHFFFAOYSA-N 315140 (2R/2S)-3-[3-({(2R/2S)-2-Cyclopentyl-2-[4-(5-fluoro-6-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid::US10172814, Example 82 Prostaglandin G/H synthase 2 Human 90.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315140 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315140&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426860 383541941 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612069 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C)C(O)=O InChI=1S/C30H33ClN2O3/c1-18(30(35)36)15-24-9-6-10-27(19(24)2)33-29(34)28(22-7-4-5-8-22)23-13-11-21(12-14-23)25-16-26(31)20(3)32-17-25/h6,9-14,16-18,22,28H,4-5,7-8,15H2,1-3H3,(H,33,34)(H,35,36) BMEVSHZHBKJEQI-UHFFFAOYSA-N 315141 3-[3-({[4-(5-Chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 84::US10172814, Example 83 Prostaglandin G/H synthase 2 Human 11700 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315141&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417156 383541942 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612070 CC(Cc1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C)C(O)=O InChI=1S/C30H33ClN2O3/c1-18(30(35)36)15-24-9-6-10-27(19(24)2)33-29(34)28(22-7-4-5-8-22)23-13-11-21(12-14-23)25-16-26(31)20(3)32-17-25/h6,9-14,16-18,22,28H,4-5,7-8,15H2,1-3H3,(H,33,34)(H,35,36) BMEVSHZHBKJEQI-UHFFFAOYSA-N 315141 3-[3-({[4-(5-Chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]-2-methylpropanoic acid, Stereoisomer 1::US10172814, Example 84::US10172814, Example 83 Prostaglandin G/H synthase 2 Human 41.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315141 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315141&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417156 383541942 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612071 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 29.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612072 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 208 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612073 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 9.67 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612074 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 961 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612075 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 22.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612076 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(C)CC(O)=O)c1C InChI=1S/C31H36N2O4/c1-4-37-26-17-25(18-32-19-26)22-12-14-24(15-13-22)30(23-8-5-6-9-23)31(36)33-28-11-7-10-27(21(28)3)20(2)16-29(34)35/h7,10-15,17-20,23,30H,4-6,8-9,16H2,1-3H3,(H,33,36)(H,34,35) XIYUOXBUCDBVRJ-UHFFFAOYSA-N 315148 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 90 Prostaglandin G/H synthase 2 Human 108 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315148 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315148&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426918 383541944 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612077 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H31F3N2O3/c1-18(14-27(36)37)25-8-5-9-26(19(25)2)35-29(38)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(17-34-16-23)30(31,32)33/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,35,38)(H,36,37) DWZJFPYNRIXPLD-UHFFFAOYSA-N 315149 (3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 91 Prostaglandin G/H synthase 2 Human 20.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315149 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315149&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426965 383541945 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612078 CCc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(C)CC(O)=O)c1C InChI=1S/C31H36N2O3/c1-4-22-17-26(19-32-18-22)23-12-14-25(15-13-23)30(24-8-5-6-9-24)31(36)33-28-11-7-10-27(21(28)3)20(2)16-29(34)35/h7,10-15,17-20,24,30H,4-6,8-9,16H2,1-3H3,(H,33,36)(H,34,35) IROYHFMHLMRKKF-UHFFFAOYSA-N 315150 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-ethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 92 Prostaglandin G/H synthase 2 Human 22.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315150 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315150&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426864 383541946 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612079 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(C)c2)c1C InChI=1S/C31H36N2O3/c1-19-16-26(18-32-22(19)4)23-12-14-25(15-13-23)30(24-8-5-6-9-24)31(36)33-28-11-7-10-27(21(28)3)20(2)17-29(34)35/h7,10-16,18,20,24,30H,5-6,8-9,17H2,1-4H3,(H,33,36)(H,34,35) PYPRCDQBPKZGJN-UHFFFAOYSA-N 315151 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5,6-dimethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 93 Prostaglandin G/H synthase 2 Human 35.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315151 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315151&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426926 383541947 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612080 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(C)c2)c1C InChI=1S/C30H34N2O3/c1-19-15-25(18-31-17-19)22-11-13-24(14-12-22)29(23-7-4-5-8-23)30(35)32-27-10-6-9-26(21(27)3)20(2)16-28(33)34/h6,9-15,17-18,20,23,29H,4-5,7-8,16H2,1-3H3,(H,32,35)(H,33,34) PETYQIBTTFCTGV-UHFFFAOYSA-N 315152 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 94 Prostaglandin G/H synthase 2 Human 32.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315152 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315152&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426865 383541948 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612081 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(F)c2)c1C InChI=1S/C29H31FN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) HIXGAFWPRNEJSA-UHFFFAOYSA-N 315153 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-fluoropyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 95 Prostaglandin G/H synthase 2 Human 41.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315153 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315153&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426950 383541949 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612082 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(F)c2)c1C InChI=1S/C30H33FN2O3/c1-18(15-28(34)35)25-9-6-10-27(19(25)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-16-26(31)20(3)32-17-24/h6,9-14,16-18,22,29H,4-5,7-8,15H2,1-3H3,(H,33,36)(H,34,35) DMWLCLJRDSZTGM-UHFFFAOYSA-N 315154 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Fluoro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 96 Prostaglandin G/H synthase 2 Human 36.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315154 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315154&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426920 383541950 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612083 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-18(15-28(34)35)25-9-6-10-27(19(25)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-16-26(31)20(3)32-17-24/h6,9-14,16-18,22,29H,4-5,7-8,15H2,1-3H3,(H,33,36)(H,34,35) OKWXXDPDTCCZHE-UHFFFAOYSA-N 315155 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 97 Prostaglandin G/H synthase 2 Human 13.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315155 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315155&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426924 383541951 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612084 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)F)c1C InChI=1S/C30H32F2N2O3/c1-18(14-27(35)36)25-8-5-9-26(19(25)2)34-30(37)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(29(31)32)17-33-16-23/h5,8-13,15-18,21,28-29H,3-4,6-7,14H2,1-2H3,(H,34,37)(H,35,36) DSMSBSUDPPTYER-UHFFFAOYSA-N 315156 (3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{4-[5-(difluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 98 Prostaglandin G/H synthase 2 Human 33.8 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315156 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315156&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426859 383541952 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612085 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) XISHDDDEWVNNQR-UHFFFAOYSA-N 315157 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 103::US10172814, Example 101::US10172814, Example 102::US10172814, Example 100::US10172814, Example 99 Prostaglandin G/H synthase 2 Human 37.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315157&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417092 383541953 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612086 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) XISHDDDEWVNNQR-UHFFFAOYSA-N 315157 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 103::US10172814, Example 101::US10172814, Example 102::US10172814, Example 100::US10172814, Example 99 Prostaglandin G/H synthase 2 Human 11.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315157&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417092 383541953 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612087 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) XISHDDDEWVNNQR-UHFFFAOYSA-N 315157 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 103::US10172814, Example 101::US10172814, Example 102::US10172814, Example 100::US10172814, Example 99 Prostaglandin G/H synthase 2 Human 166 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315157&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417092 383541953 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612088 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) XISHDDDEWVNNQR-UHFFFAOYSA-N 315157 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 103::US10172814, Example 101::US10172814, Example 102::US10172814, Example 100::US10172814, Example 99 Prostaglandin G/H synthase 2 Human >20000 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315157&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417092 383541953 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612089 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C30H33ClN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) XISHDDDEWVNNQR-UHFFFAOYSA-N 315157 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 103::US10172814, Example 101::US10172814, Example 102::US10172814, Example 100::US10172814, Example 99 Prostaglandin G/H synthase 2 Human 278 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315157 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315157&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417092 383541953 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612090 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(C)c2)c1C InChI=1S/C31H36N2O3/c1-4-22(17-29(34)35)27-10-7-11-28(21(27)3)33-31(36)30(24-8-5-6-9-24)25-14-12-23(13-15-25)26-16-20(2)18-32-19-26/h7,10-16,18-19,22,24,30H,4-6,8-9,17H2,1-3H3,(H,33,36)(H,34,35) IEGLKVMOMXPPHD-UHFFFAOYSA-N 315162 (3R/S)-3-[3-({(2RS)-2-Cyclopentyl-2-[4-(5-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 104 Prostaglandin G/H synthase 2 Human 95.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315162 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315162&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426925 383541954 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612091 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(CC)c2)c1C InChI=1S/C32H38N2O3/c1-4-22-17-27(20-33-19-22)24-13-15-26(16-14-24)31(25-9-6-7-10-25)32(37)34-29-12-8-11-28(21(29)3)23(5-2)18-30(35)36/h8,11-17,19-20,23,25,31H,4-7,9-10,18H2,1-3H3,(H,34,37)(H,35,36) YCZXGDRTZAULOW-UHFFFAOYSA-N 315163 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-ethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 105 Prostaglandin G/H synthase 2 Human 12.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315163 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315163&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426901 383541955 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612092 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(F)c2)c1C InChI=1S/C30H33FN2O3/c1-3-20(16-28(34)35)26-9-6-10-27(19(26)2)33-30(36)29(22-7-4-5-8-22)23-13-11-21(12-14-23)24-15-25(31)18-32-17-24/h6,9-15,17-18,20,22,29H,3-5,7-8,16H2,1-2H3,(H,33,36)(H,34,35) LPFGOLSPERPONH-UHFFFAOYSA-N 315164 3-[3-({[4-(5-Fluoropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]pentanoic acid, Stereoisomer 4::US10172814, Example 106 Prostaglandin G/H synthase 2 Human 156 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315164 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315164&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417276 383541956 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612093 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(CC)CC(O)=O)c1C InChI=1S/C32H38N2O4/c1-4-22(18-30(35)36)28-11-8-12-29(21(28)3)34-32(37)31(24-9-6-7-10-24)25-15-13-23(14-16-25)26-17-27(38-5-2)20-33-19-26/h8,11-17,19-20,22,24,31H,4-7,9-10,18H2,1-3H3,(H,34,37)(H,35,36) XZBMGAHQZOBBRS-UHFFFAOYSA-N 315165 (3R/S)-3-[3-({(2R/S)-2-Cyclopentyl-2-[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid::US10172814, Example 107 Prostaglandin G/H synthase 2 Human 106 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315165 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315165&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426919 383541957 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612094 Cc1ncc(cc1Cl)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(CC(O)=O)C2CC2)c1C InChI=1S/C32H35ClN2O3/c1-19-26(27(17-30(36)37)22-12-13-22)8-5-9-29(19)35-32(38)31(23-6-3-4-7-23)24-14-10-21(11-15-24)25-16-28(33)20(2)34-18-25/h5,8-11,14-16,18,22-23,27,31H,3-4,6-7,12-13,17H2,1-2H3,(H,35,38)(H,36,37) QMYTUEPSONUWAU-UHFFFAOYSA-N 315166 (3R/S)-3-[3-({(2R/S)-2-[4-(5-chloro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-3-cyclopropylpropanoic acid::US10172814, Example 108 Prostaglandin G/H synthase 2 Human 31.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315166 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315166&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426902 383541958 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612095 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)cccc1C(CC(O)=O)C1CC1 InChI=1S/C32H33F3N2O3/c1-19-26(27(16-29(38)39)21-11-12-21)7-4-8-28(19)37-31(40)30(22-5-2-3-6-22)23-13-9-20(10-14-23)24-15-25(18-36-17-24)32(33,34)35/h4,7-10,13-15,17-18,21-22,27,30H,2-3,5-6,11-12,16H2,1H3,(H,37,40)(H,38,39) ZSTWDXWFIBXBEX-UHFFFAOYSA-N 315167 (3R/S)-3-(3-{[(2R/S)-2-cyclopentyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)-3-cyclopropylpropanoic acid::US10172814, Example 109 Prostaglandin G/H synthase 2 Human 24.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315167 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315167&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426927 383541959 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612096 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)cccc1C(CC(O)=O)C1CC1 InChI=1S/C31H33ClN2O3/c1-19-26(27(16-29(35)36)21-11-12-21)7-4-8-28(19)34-31(37)30(22-5-2-3-6-22)23-13-9-20(10-14-23)24-15-25(32)18-33-17-24/h4,7-10,13-15,17-18,21-22,27,30H,2-3,5-6,11-12,16H2,1H3,(H,34,37)(H,35,36) LFESUWHPROTLEJ-UHFFFAOYSA-N 315168 (3R/S)-3-[3-({(2R/S)-2-[4-(5-chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-3-cyclopropylpropanoic acid::US10172814, Example 110 Prostaglandin G/H synthase 2 Human 54.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315168 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315168&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426915 383541960 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612097 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(CC(O)=O)C2CC2)c1C InChI=1S/C33H38N2O4/c1-3-39-27-17-26(19-34-20-27)22-11-15-25(16-12-22)32(24-7-4-5-8-24)33(38)35-30-10-6-9-28(21(30)2)29(18-31(36)37)23-13-14-23/h6,9-12,15-17,19-20,23-24,29,32H,3-5,7-8,13-14,18H2,1-2H3,(H,35,38)(H,36,37) BKFURPOUIAFQSU-UHFFFAOYSA-N 315169 (3R/S)-3-[3-({(2R/S)-2-cyclopentyl-2-[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-3-cyclopropylpropanoic acid::US10172814, Example 111 Prostaglandin G/H synthase 2 Human 53.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315169 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315169&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426862 383541961 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612098 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(F)c2)cccc1C(CC(O)=O)C1CC1 InChI=1S/C31H33FN2O3/c1-19-26(27(16-29(35)36)21-11-12-21)7-4-8-28(19)34-31(37)30(22-5-2-3-6-22)23-13-9-20(10-14-23)24-15-25(32)18-33-17-24/h4,7-10,13-15,17-18,21-22,27,30H,2-3,5-6,11-12,16H2,1H3,(H,34,37)(H,35,36) GQVKKBSMJPRROY-UHFFFAOYSA-N 315170 (3R/S)-3-[3-({(2R/S)-2-cyclopentyl-2-[4-(5-fluoropyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-3-cyclopropylpropanoic acid::US10172814, Example 112 Prostaglandin G/H synthase 2 Human 51.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315170 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315170&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426866 383541962 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612099 Cc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(CC(O)=O)C2CC2)c1C InChI=1S/C32H36N2O3/c1-20-16-26(19-33-18-20)22-10-14-25(15-11-22)31(24-6-3-4-7-24)32(37)34-29-9-5-8-27(21(29)2)28(17-30(35)36)23-12-13-23/h5,8-11,14-16,18-19,23-24,28,31H,3-4,6-7,12-13,17H2,1-2H3,(H,34,37)(H,35,36) ODWAKTAIFXOWDU-UHFFFAOYSA-N 315171 (3R/S)-3-[3-({(2R/S)-2-cyclopentyl-2-[4-(5-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]-3-cyclopropylpropanoic acid::US10172814, Example 113 Prostaglandin G/H synthase 2 Human 140 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315171 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315171&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426913 383541963 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612100 CCc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C(CC(O)=O)C2CC2)c1C InChI=1S/C33H38N2O3/c1-3-22-17-27(20-34-19-22)23-11-15-26(16-12-23)32(25-7-4-5-8-25)33(38)35-30-10-6-9-28(21(30)2)29(18-31(36)37)24-13-14-24/h6,9-12,15-17,19-20,24-25,29,32H,3-5,7-8,13-14,18H2,1-2H3,(H,35,38)(H,36,37) SCULGKAPLBZFHZ-UHFFFAOYSA-N 315172 US10172814, Example 114 Prostaglandin G/H synthase 2 Human 29.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315172 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315172&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426904 383541964 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612101 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H30F4N2O3/c1-17(12-27(37)38)23-8-5-9-26(18(23)2)36-29(39)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(16-35-15-21)30(32,33)34/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,36,39)(H,37,38) PNTWDHSKZJLEGP-UHFFFAOYSA-N 315173 US10172814, Example 118::US10172814, Example 119::US10172814, Example 116::US10172814, Example 117::(3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 115 Prostaglandin G/H synthase 2 Human 18.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315173&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417124 383541965 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612102 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H30F4N2O3/c1-17(12-27(37)38)23-8-5-9-26(18(23)2)36-29(39)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(16-35-15-21)30(32,33)34/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,36,39)(H,37,38) PNTWDHSKZJLEGP-UHFFFAOYSA-N 315173 US10172814, Example 118::US10172814, Example 119::US10172814, Example 116::US10172814, Example 117::(3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 115 Prostaglandin G/H synthase 2 Human 3.49 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315173&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417124 383541965 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612103 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H30F4N2O3/c1-17(12-27(37)38)23-8-5-9-26(18(23)2)36-29(39)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(16-35-15-21)30(32,33)34/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,36,39)(H,37,38) PNTWDHSKZJLEGP-UHFFFAOYSA-N 315173 US10172814, Example 118::US10172814, Example 119::US10172814, Example 116::US10172814, Example 117::(3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 115 Prostaglandin G/H synthase 2 Human 15.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315173&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417124 383541965 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612104 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H30F4N2O3/c1-17(12-27(37)38)23-8-5-9-26(18(23)2)36-29(39)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(16-35-15-21)30(32,33)34/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,36,39)(H,37,38) PNTWDHSKZJLEGP-UHFFFAOYSA-N 315173 US10172814, Example 118::US10172814, Example 119::US10172814, Example 116::US10172814, Example 117::(3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 115 Prostaglandin G/H synthase 2 Human 383 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315173&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417124 383541965 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612105 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C30H30F4N2O3/c1-17(12-27(37)38)23-8-5-9-26(18(23)2)36-29(39)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(16-35-15-21)30(32,33)34/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,36,39)(H,37,38) PNTWDHSKZJLEGP-UHFFFAOYSA-N 315173 US10172814, Example 118::US10172814, Example 119::US10172814, Example 116::US10172814, Example 117::(3R/S)-3-(3-{[(2R/S)-2-Cyclopentyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 115 Prostaglandin G/H synthase 2 Human 1060 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315173 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315173&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417124 383541965 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612106 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H32ClFN2O3/c1-17(13-28(35)36)23-9-6-10-27(18(23)2)34-30(37)29(20-7-4-5-8-20)21-11-12-24(26(32)15-21)22-14-25(31)19(3)33-16-22/h6,9-12,14-17,20,29H,4-5,7-8,13H2,1-3H3,(H,34,37)(H,35,36) WVFCPUMLDXWLRI-UHFFFAOYSA-N 315178 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 123::US10172814, Example 124::US10172814, Example 121::US10172814, Example 122::US10172814, Example 120 Prostaglandin G/H synthase 2 Human 15.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315178&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417072 383541966 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612107 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H32ClFN2O3/c1-17(13-28(35)36)23-9-6-10-27(18(23)2)34-30(37)29(20-7-4-5-8-20)21-11-12-24(26(32)15-21)22-14-25(31)19(3)33-16-22/h6,9-12,14-17,20,29H,4-5,7-8,13H2,1-3H3,(H,34,37)(H,35,36) WVFCPUMLDXWLRI-UHFFFAOYSA-N 315178 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 123::US10172814, Example 124::US10172814, Example 121::US10172814, Example 122::US10172814, Example 120 Prostaglandin G/H synthase 2 Human 382 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315178&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417072 383541966 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612108 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H32ClFN2O3/c1-17(13-28(35)36)23-9-6-10-27(18(23)2)34-30(37)29(20-7-4-5-8-20)21-11-12-24(26(32)15-21)22-14-25(31)19(3)33-16-22/h6,9-12,14-17,20,29H,4-5,7-8,13H2,1-3H3,(H,34,37)(H,35,36) WVFCPUMLDXWLRI-UHFFFAOYSA-N 315178 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 123::US10172814, Example 124::US10172814, Example 121::US10172814, Example 122::US10172814, Example 120 Prostaglandin G/H synthase 2 Human 22.8 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315178&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417072 383541966 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612109 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H32ClFN2O3/c1-17(13-28(35)36)23-9-6-10-27(18(23)2)34-30(37)29(20-7-4-5-8-20)21-11-12-24(26(32)15-21)22-14-25(31)19(3)33-16-22/h6,9-12,14-17,20,29H,4-5,7-8,13H2,1-3H3,(H,34,37)(H,35,36) WVFCPUMLDXWLRI-UHFFFAOYSA-N 315178 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 123::US10172814, Example 124::US10172814, Example 121::US10172814, Example 122::US10172814, Example 120 Prostaglandin G/H synthase 2 Human 646 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315178&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417072 383541966 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612110 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C30H32ClFN2O3/c1-17(13-28(35)36)23-9-6-10-27(18(23)2)34-30(37)29(20-7-4-5-8-20)21-11-12-24(26(32)15-21)22-14-25(31)19(3)33-16-22/h6,9-12,14-17,20,29H,4-5,7-8,13H2,1-3H3,(H,34,37)(H,35,36) WVFCPUMLDXWLRI-UHFFFAOYSA-N 315178 (3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 123::US10172814, Example 124::US10172814, Example 121::US10172814, Example 122::US10172814, Example 120 Prostaglandin G/H synthase 2 Human 5.06 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315178 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315178&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417072 383541966 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612111 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C29H30ClFN2O3/c1-17(12-27(34)35)23-8-5-9-26(18(23)2)33-29(36)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(30)16-32-15-21/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,33,36)(H,34,35) ODEOIVMERLBKGZ-UHFFFAOYSA-N 315183 US10172814, Example 129::US10172814, Example 127::US10172814, Example 128::US10172814, Example 126::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 125 Prostaglandin G/H synthase 2 Human 22.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315183&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417145 383541967 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612112 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C29H30ClFN2O3/c1-17(12-27(34)35)23-8-5-9-26(18(23)2)33-29(36)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(30)16-32-15-21/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,33,36)(H,34,35) ODEOIVMERLBKGZ-UHFFFAOYSA-N 315183 US10172814, Example 129::US10172814, Example 127::US10172814, Example 128::US10172814, Example 126::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 125 Prostaglandin G/H synthase 2 Human 646 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315183&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417145 383541967 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612113 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C29H30ClFN2O3/c1-17(12-27(34)35)23-8-5-9-26(18(23)2)33-29(36)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(30)16-32-15-21/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,33,36)(H,34,35) ODEOIVMERLBKGZ-UHFFFAOYSA-N 315183 US10172814, Example 129::US10172814, Example 127::US10172814, Example 128::US10172814, Example 126::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 125 Prostaglandin G/H synthase 2 Human 31.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315183&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417145 383541967 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612114 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C29H30ClFN2O3/c1-17(12-27(34)35)23-8-5-9-26(18(23)2)33-29(36)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(30)16-32-15-21/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,33,36)(H,34,35) ODEOIVMERLBKGZ-UHFFFAOYSA-N 315183 US10172814, Example 129::US10172814, Example 127::US10172814, Example 128::US10172814, Example 126::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 125 Prostaglandin G/H synthase 2 Human 1730 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315183&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417145 383541967 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612115 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C29H30ClFN2O3/c1-17(12-27(34)35)23-8-5-9-26(18(23)2)33-29(36)28(19-6-3-4-7-19)20-10-11-24(25(31)14-20)21-13-22(30)16-32-15-21/h5,8-11,13-17,19,28H,3-4,6-7,12H2,1-2H3,(H,33,36)(H,34,35) ODEOIVMERLBKGZ-UHFFFAOYSA-N 315183 US10172814, Example 129::US10172814, Example 127::US10172814, Example 128::US10172814, Example 126::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 125 Prostaglandin G/H synthase 2 Human 5.60 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315183 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315183&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417145 383541967 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612116 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F3N2O3/c1-17(13-26(35)36)24-7-4-8-25(18(24)2)34-28(37)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(16-33-15-22)29(30,31)32/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,34,37)(H,35,36) QTYZIHUQYLPTEJ-UHFFFAOYSA-N 315188 (3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 134::US10172814, Example 132::US10172814, Example 133::US10172814, Example 131::US10172814, Example 130 Prostaglandin G/H synthase 2 Human 72.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315188&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417022 383541968 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612117 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F3N2O3/c1-17(13-26(35)36)24-7-4-8-25(18(24)2)34-28(37)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(16-33-15-22)29(30,31)32/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,34,37)(H,35,36) QTYZIHUQYLPTEJ-UHFFFAOYSA-N 315188 (3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 134::US10172814, Example 132::US10172814, Example 133::US10172814, Example 131::US10172814, Example 130 Prostaglandin G/H synthase 2 Human 1020 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315188&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417022 383541968 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612118 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F3N2O3/c1-17(13-26(35)36)24-7-4-8-25(18(24)2)34-28(37)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(16-33-15-22)29(30,31)32/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,34,37)(H,35,36) QTYZIHUQYLPTEJ-UHFFFAOYSA-N 315188 (3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 134::US10172814, Example 132::US10172814, Example 133::US10172814, Example 131::US10172814, Example 130 Prostaglandin G/H synthase 2 Human 38.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315188&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417022 383541968 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612119 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F3N2O3/c1-17(13-26(35)36)24-7-4-8-25(18(24)2)34-28(37)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(16-33-15-22)29(30,31)32/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,34,37)(H,35,36) QTYZIHUQYLPTEJ-UHFFFAOYSA-N 315188 (3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 134::US10172814, Example 132::US10172814, Example 133::US10172814, Example 131::US10172814, Example 130 Prostaglandin G/H synthase 2 Human 1770 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315188&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417022 383541968 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612120 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F3N2O3/c1-17(13-26(35)36)24-7-4-8-25(18(24)2)34-28(37)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(16-33-15-22)29(30,31)32/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,34,37)(H,35,36) QTYZIHUQYLPTEJ-UHFFFAOYSA-N 315188 (3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 134::US10172814, Example 132::US10172814, Example 133::US10172814, Example 131::US10172814, Example 130 Prostaglandin G/H synthase 2 Human 7.59 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315188&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417022 383541968 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612121 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C28H29ClN2O3/c1-17(13-26(32)33)24-7-4-8-25(18(24)2)31-28(34)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(29)16-30-15-22/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,31,34)(H,32,33) XNBPXLUHPUNUOO-UHFFFAOYSA-N 315193 US10172814, Example 138::US10172814, Example 139::US10172814, Example 136::US10172814, Example 137::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 135 Prostaglandin G/H synthase 2 Human 86.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315193&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417266 383541969 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612122 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C28H29ClN2O3/c1-17(13-26(32)33)24-7-4-8-25(18(24)2)31-28(34)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(29)16-30-15-22/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,31,34)(H,32,33) XNBPXLUHPUNUOO-UHFFFAOYSA-N 315193 US10172814, Example 138::US10172814, Example 139::US10172814, Example 136::US10172814, Example 137::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 135 Prostaglandin G/H synthase 2 Human 12.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315193&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417266 383541969 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612123 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C28H29ClN2O3/c1-17(13-26(32)33)24-7-4-8-25(18(24)2)31-28(34)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(29)16-30-15-22/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,31,34)(H,32,33) XNBPXLUHPUNUOO-UHFFFAOYSA-N 315193 US10172814, Example 138::US10172814, Example 139::US10172814, Example 136::US10172814, Example 137::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 135 Prostaglandin G/H synthase 2 Human 2900 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315193&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417266 383541969 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612124 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C28H29ClN2O3/c1-17(13-26(32)33)24-7-4-8-25(18(24)2)31-28(34)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(29)16-30-15-22/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,31,34)(H,32,33) XNBPXLUHPUNUOO-UHFFFAOYSA-N 315193 US10172814, Example 138::US10172814, Example 139::US10172814, Example 136::US10172814, Example 137::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 135 Prostaglandin G/H synthase 2 Human 2040 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315193&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417266 383541969 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612125 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C28H29ClN2O3/c1-17(13-26(32)33)24-7-4-8-25(18(24)2)31-28(34)27(20-5-3-6-20)21-11-9-19(10-12-21)22-14-23(29)16-30-15-22/h4,7-12,14-17,20,27H,3,5-6,13H2,1-2H3,(H,31,34)(H,32,33) XNBPXLUHPUNUOO-UHFFFAOYSA-N 315193 US10172814, Example 138::US10172814, Example 139::US10172814, Example 136::US10172814, Example 137::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 135 Prostaglandin G/H synthase 2 Human 107 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315193&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417266 383541969 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612126 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-17(14-27(33)34)24-8-5-9-26(18(24)2)32-29(35)28(21-6-4-7-21)22-12-10-20(11-13-22)23-15-25(30)19(3)31-16-23/h5,8-13,15-17,21,28H,4,6-7,14H2,1-3H3,(H,32,35)(H,33,34) WUXMFDWIWUSRIQ-UHFFFAOYSA-N 315198 US10172814, Example 143::US10172814, Example 144::US10172814, Example 141::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 142::US10172814, Example 140 Prostaglandin G/H synthase 2 Human 35.8 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315198&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417232 383541970 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612127 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-17(14-27(33)34)24-8-5-9-26(18(24)2)32-29(35)28(21-6-4-7-21)22-12-10-20(11-13-22)23-15-25(30)19(3)31-16-23/h5,8-13,15-17,21,28H,4,6-7,14H2,1-3H3,(H,32,35)(H,33,34) WUXMFDWIWUSRIQ-UHFFFAOYSA-N 315198 US10172814, Example 143::US10172814, Example 144::US10172814, Example 141::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 142::US10172814, Example 140 Prostaglandin G/H synthase 2 Human 3430 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315198&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417232 383541970 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612128 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-17(14-27(33)34)24-8-5-9-26(18(24)2)32-29(35)28(21-6-4-7-21)22-12-10-20(11-13-22)23-15-25(30)19(3)31-16-23/h5,8-13,15-17,21,28H,4,6-7,14H2,1-3H3,(H,32,35)(H,33,34) WUXMFDWIWUSRIQ-UHFFFAOYSA-N 315198 US10172814, Example 143::US10172814, Example 144::US10172814, Example 141::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 142::US10172814, Example 140 Prostaglandin G/H synthase 2 Human 13.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315198&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417232 383541970 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612129 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-17(14-27(33)34)24-8-5-9-26(18(24)2)32-29(35)28(21-6-4-7-21)22-12-10-20(11-13-22)23-15-25(30)19(3)31-16-23/h5,8-13,15-17,21,28H,4,6-7,14H2,1-3H3,(H,32,35)(H,33,34) WUXMFDWIWUSRIQ-UHFFFAOYSA-N 315198 US10172814, Example 143::US10172814, Example 144::US10172814, Example 141::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 142::US10172814, Example 140 Prostaglandin G/H synthase 2 Human 349 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315198&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417232 383541970 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612130 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-17(14-27(33)34)24-8-5-9-26(18(24)2)32-29(35)28(21-6-4-7-21)22-12-10-20(11-13-22)23-15-25(30)19(3)31-16-23/h5,8-13,15-17,21,28H,4,6-7,14H2,1-3H3,(H,32,35)(H,33,34) WUXMFDWIWUSRIQ-UHFFFAOYSA-N 315198 US10172814, Example 143::US10172814, Example 144::US10172814, Example 141::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloro-6-methylpyridin-3-yl)phenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 142::US10172814, Example 140 Prostaglandin G/H synthase 2 Human 47.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315198&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417232 383541970 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612131 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H28F4N2O3/c1-16(11-26(36)37)22-7-4-8-25(17(22)2)35-28(38)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(15-34-14-20)29(31,32)33/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,35,38)(H,36,37) YTRYVMRCTNOCOL-UHFFFAOYSA-N 315203 US10172814, Example 147::US10172814, Example 148::US10172814, Example 146::(3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 145 Prostaglandin G/H synthase 2 Human 50.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315203&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417113 383541971 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612132 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H28F4N2O3/c1-16(11-26(36)37)22-7-4-8-25(17(22)2)35-28(38)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(15-34-14-20)29(31,32)33/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,35,38)(H,36,37) YTRYVMRCTNOCOL-UHFFFAOYSA-N 315203 US10172814, Example 147::US10172814, Example 148::US10172814, Example 146::(3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 145 Prostaglandin G/H synthase 2 Human 12.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315203&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417113 383541971 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612133 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H28F4N2O3/c1-16(11-26(36)37)22-7-4-8-25(17(22)2)35-28(38)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(15-34-14-20)29(31,32)33/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,35,38)(H,36,37) YTRYVMRCTNOCOL-UHFFFAOYSA-N 315203 US10172814, Example 147::US10172814, Example 148::US10172814, Example 146::(3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 145 Prostaglandin G/H synthase 2 Human 1310 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315203&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417113 383541971 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612134 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H28F4N2O3/c1-16(11-26(36)37)22-7-4-8-25(17(22)2)35-28(38)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(15-34-14-20)29(31,32)33/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,35,38)(H,36,37) YTRYVMRCTNOCOL-UHFFFAOYSA-N 315203 US10172814, Example 147::US10172814, Example 148::US10172814, Example 146::(3R/S)-3-(3-{[(2R/S)-2-Cyclobutyl-2-{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)butanoic acid::US10172814, Example 145 Prostaglandin G/H synthase 2 Human 24.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315203&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417113 383541971 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612135 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C28H28ClFN2O3/c1-16(11-26(33)34)22-7-4-8-25(17(22)2)32-28(35)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(29)15-31-14-20/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,32,35)(H,33,34) CYPUGHFYVJHLOZ-UHFFFAOYSA-N 315207 US10172814, Example 150::US10172814, Example 151::((3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 152::US10172814, Example 153::US10172814, Example 149 Prostaglandin G/H synthase 2 Human 52.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315207&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426903 383541972 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612136 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C28H28ClFN2O3/c1-16(11-26(33)34)22-7-4-8-25(17(22)2)32-28(35)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(29)15-31-14-20/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,32,35)(H,33,34) CYPUGHFYVJHLOZ-UHFFFAOYSA-N 315207 US10172814, Example 150::US10172814, Example 151::((3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 152::US10172814, Example 153::US10172814, Example 149 Prostaglandin G/H synthase 2 Human 2620 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315207&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426903 383541972 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612137 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C28H28ClFN2O3/c1-16(11-26(33)34)22-7-4-8-25(17(22)2)32-28(35)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(29)15-31-14-20/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,32,35)(H,33,34) CYPUGHFYVJHLOZ-UHFFFAOYSA-N 315207 US10172814, Example 150::US10172814, Example 151::((3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 152::US10172814, Example 153::US10172814, Example 149 Prostaglandin G/H synthase 2 Human 46.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315207&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426903 383541972 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612138 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C28H28ClFN2O3/c1-16(11-26(33)34)22-7-4-8-25(17(22)2)32-28(35)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(29)15-31-14-20/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,32,35)(H,33,34) CYPUGHFYVJHLOZ-UHFFFAOYSA-N 315207 US10172814, Example 150::US10172814, Example 151::((3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 152::US10172814, Example 153::US10172814, Example 149 Prostaglandin G/H synthase 2 Human 914 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315207&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426903 383541972 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612139 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCC2)c2ccc(c(F)c2)-c2cncc(Cl)c2)c1C InChI=1S/C28H28ClFN2O3/c1-16(11-26(33)34)22-7-4-8-25(17(22)2)32-28(35)27(18-5-3-6-18)19-9-10-23(24(30)13-19)20-12-21(29)15-31-14-20/h4,7-10,12-16,18,27H,3,5-6,11H2,1-2H3,(H,32,35)(H,33,34) CYPUGHFYVJHLOZ-UHFFFAOYSA-N 315207 US10172814, Example 150::US10172814, Example 151::((3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)-3-fluorophenyl]-2-cyclobutylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 152::US10172814, Example 153::US10172814, Example 149 Prostaglandin G/H synthase 2 Human 11.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315207&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426903 383541972 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612140 Cc1ncc(cc1Cl)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C2CC2C(O)=O)c1C InChI=1S/C30H31ClN2O3/c1-17-23(24-15-25(24)30(35)36)8-5-9-27(17)33-29(34)28(20-6-3-4-7-20)21-12-10-19(11-13-21)22-14-26(31)18(2)32-16-22/h5,8-14,16,20,24-25,28H,3-4,6-7,15H2,1-2H3,(H,33,34)(H,35,36) XVQAYESKKKCYBE-UHFFFAOYSA-N 315212 2-[3-({2-[4-(5-chloro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]cyclopropanecarboxylic acid::US10172814, Example 154 Prostaglandin G/H synthase 2 Human 42.8 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315212&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417268 383541973 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612141 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(C2CC2C(O)=O)c1C InChI=1S/C31H34N2O4/c1-3-37-24-15-23(17-32-18-24)20-11-13-22(14-12-20)29(21-7-4-5-8-21)30(34)33-28-10-6-9-25(19(28)2)26-16-27(26)31(35)36/h6,9-15,17-18,21,26-27,29H,3-5,7-8,16H2,1-2H3,(H,33,34)(H,35,36) IMUONEBAXMULCV-UHFFFAOYSA-N 315213 2-[3-({2-cyclopentyl-2-[4-(5-ethoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]cyclopropanecarboxylic acid::US10172814, Example 155 Prostaglandin G/H synthase 2 Human 158 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315213&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417041 383541974 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612142 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)cccc1C1CC1C(O)=O InChI=1S/C30H29F3N2O3/c1-17-23(24-14-25(24)29(37)38)7-4-8-26(17)35-28(36)27(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(16-34-15-21)30(31,32)33/h4,7-13,15-16,19,24-25,27H,2-3,5-6,14H2,1H3,(H,35,36)(H,37,38) PIGMVYYJRQEYNJ-UHFFFAOYSA-N 315214 2-(3-{[2-cyclopentyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)cyclopropanecarboxylic acid::US10172814, Example 156 Prostaglandin G/H synthase 2 Human 32.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315214&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417121 383541975 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612143 Cc1c(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)cccc1C1CC1C(O)=O InChI=1S/C29H29ClN2O3/c1-17-23(24-14-25(24)29(34)35)7-4-8-26(17)32-28(33)27(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(30)16-31-15-21/h4,7-13,15-16,19,24-25,27H,2-3,5-6,14H2,1H3,(H,32,33)(H,34,35) TZVOLYZIRGQFOF-UHFFFAOYSA-N 315215 -2-(3-{[2-cyclopentyl-2-{4-[5-chloropyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)cyclopropanecarboxylic acid::US10172814, Example 157 Prostaglandin G/H synthase 2 Human 29.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315215&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417175 383541976 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612144 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1Cl)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28ClF3N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)23-11-9-20(14-24(23)30)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) YJQZWOJTRNXAMW-UHFFFAOYSA-N 315216 (R/S) 3-(3-{[{2-chloro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}(cyclopentyl)acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 161 Prostaglandin G/H synthase 2 Human 278 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315216&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426959 383541977 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612145 Cc1c(CCC(O)=O)cc(F)cc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-21(10-11-26(36)37)13-24(30)14-25(17)35-28(38)27(19-4-2-3-5-19)20-8-6-18(7-9-20)22-12-23(16-34-15-22)29(31,32)33/h6-9,12-16,19,27H,2-5,10-11H2,1H3,(H,35,38)(H,36,37) WRNCTUVJYUAAIU-UHFFFAOYSA-N 315217 (R/S) 3-{3-[(cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-5-fluoro-2-methylphenyl}propanoic acid::US10172814, Example 167 Prostaglandin G/H synthase 2 Human 295 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315217&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426930 383541978 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612146 Cc1c(CCC(O)=O)cc(F)cc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-21(10-11-26(33)34)13-24(30)14-25(17)32-28(35)27(19-4-2-3-5-19)20-8-6-18(7-9-20)22-12-23(29)16-31-15-22/h6-9,12-16,19,27H,2-5,10-11H2,1H3,(H,32,35)(H,33,34) LBRXLBPCLCHGHS-UHFFFAOYSA-N 315218 (R/S) 3-[3-({[4-(5-chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-5-fluoro-2-methylphenyl]propanoic acid::US10172814, Example 168 Prostaglandin G/H synthase 2 Human 1190 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315218&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426921 383541979 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612147 Cc1ncc(cc1Cl)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cc(F)cc(CCC(O)=O)c1C InChI=1S/C29H30ClFN2O3/c1-17-22(11-12-27(34)35)13-24(31)15-26(17)33-29(36)28(20-5-3-4-6-20)21-9-7-19(8-10-21)23-14-25(30)18(2)32-16-23/h7-10,13-16,20,28H,3-6,11-12H2,1-2H3,(H,33,36)(H,34,35) FRVHHWCNMORGDK-UHFFFAOYSA-N 315219 (R/S) 3-[3-({[4-(5-chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-5-fluoro-2-methylphenyl]propanoic acid::US10172814, Example 169 Prostaglandin G/H synthase 2 Human 254 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315219&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416993 383541980 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612148 CCOc1cncc(c1)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cc(F)cc(CCC(O)=O)c1C InChI=1S/C30H33FN2O4/c1-3-37-26-15-24(17-32-18-26)20-8-10-22(11-9-20)29(21-6-4-5-7-21)30(36)33-27-16-25(31)14-23(19(27)2)12-13-28(34)35/h8-11,14-18,21,29H,3-7,12-13H2,1-2H3,(H,33,36)(H,34,35) DKJNRQYOATUQSD-UHFFFAOYSA-N 315220 (R/S) 3-[3-({[4-(5-ethoxypyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-5-fluoro-2-methylphenyl]propanoic acid::US10172814, Example 170 Prostaglandin G/H synthase 2 Human 573 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315220&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426867 383541981 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612149 Cc1c(NCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H28F3N3O3/c1-17-23(33-16-25(35)36)7-4-8-24(17)34-27(37)26(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(15-32-14-21)28(29,30)31/h4,7-15,19,26,33H,2-3,5-6,16H2,1H3,(H,34,37)(H,35,36) SKCXKQTWQQFWDU-UHFFFAOYSA-N 315221 US10172814, Example 171 Prostaglandin G/H synthase 2 Human 319 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315221&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426871 383541982 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612150 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(Cl)cc1-c1cncc(Cl)c1 InChI=1S/C29H30Cl2N2O3/c1-17-12-24(25(31)14-23(17)21-13-22(30)16-32-15-21)28(20-6-3-4-7-20)29(36)33-26-9-5-8-19(18(26)2)10-11-27(34)35/h5,8-9,12-16,20,28H,3-4,6-7,10-11H2,1-2H3,(H,33,36)(H,34,35) OEOZOGVRFAIGDN-UHFFFAOYSA-N 315222 (R/S) 3-[3-({[2-chloro-4-(5-chloropyridin-3-yl)-5-methylphenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 172 Prostaglandin G/H synthase 2 Human 1860 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315222&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426916 383541983 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612151 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(Cl)cc1-c1cncc(c1)C(F)(F)F InChI=1S/C30H30ClF3N2O3/c1-17-12-24(25(31)14-23(17)21-13-22(16-35-15-21)30(32,33)34)28(20-6-3-4-7-20)29(39)36-26-9-5-8-19(18(26)2)10-11-27(37)38/h5,8-9,12-16,20,28H,3-4,6-7,10-11H2,1-2H3,(H,36,39)(H,37,38) SVZNVJJTDUBPCR-UHFFFAOYSA-N 315223 (R/S) 3-(3-{[{2-chloro-5-methyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}(cyclopentyl)acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 173 Prostaglandin G/H synthase 2 Human 1240 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315223&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426922 383541984 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612152 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(Cl)cc1-c1cnc(C)c(Cl)c1 InChI=1S/C30H32Cl2N2O3/c1-17-13-24(26(32)15-23(17)22-14-25(31)19(3)33-16-22)29(21-7-4-5-8-21)30(37)34-27-10-6-9-20(18(27)2)11-12-28(35)36/h6,9-10,13-16,21,29H,4-5,7-8,11-12H2,1-3H3,(H,34,37)(H,35,36) IIJGWCAVHINFEW-UHFFFAOYSA-N 315224 (R/S) 3-[3-({[2-chloro-4-(5-chloro-6-methylpyridin-3-yl)-5-methylphenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 174 Prostaglandin G/H synthase 2 Human 444 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315224&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426868 383541985 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612153 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(Cl)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28ClF3N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) CYQRGESYDMHMAI-UHFFFAOYSA-N 315225 (R/S) 3-[3-({[3-chloro-4-(5-(trifluoromethyl)pyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 175 Prostaglandin G/H synthase 2 Human 34.6 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315225&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426928 383541986 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612154 Cc1ncc(cc1Cl)-c1ccc(cc1Cl)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H30Cl2N2O3/c1-17-19(11-13-27(34)35)8-5-9-26(17)33-29(36)28(20-6-3-4-7-20)21-10-12-23(25(31)14-21)22-15-24(30)18(2)32-16-22/h5,8-10,12,14-16,20,28H,3-4,6-7,11,13H2,1-2H3,(H,33,36)(H,34,35) JLTFIQJFOCRBMI-UHFFFAOYSA-N 315226 (R/S) 3-[3-({[3-chloro-4-(5-chloro-6-methylpyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 176 Prostaglandin G/H synthase 2 Human 198 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315226&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426931 383541987 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612155 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(Cl)c1)-c1cncc(Cl)c1 InChI=1S/C28H28Cl2N2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) VUCVLYWSBCNCGC-UHFFFAOYSA-N 315227 (R/S) 3-[3-({[3-chloro-4-(5-chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 177 Prostaglandin G/H synthase 2 Human 70.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315227 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315227&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426971 383541988 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612156 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1cc(F)c(cc1F)-c1cncc(Cl)c1 InChI=1S/C28H27ClF2N2O3/c1-16-17(9-10-26(34)35)7-4-8-25(16)33-28(36)27(18-5-2-3-6-18)22-13-23(30)21(12-24(22)31)19-11-20(29)15-32-14-19/h4,7-8,11-15,18,27H,2-3,5-6,9-10H2,1H3,(H,33,36)(H,34,35) DTSMSQVJQWGIJS-UHFFFAOYSA-N 315228 (R/S) 3-[3-({[4-(5-chloropyridin-3-yl)-2,5-difluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 178 Prostaglandin G/H synthase 2 Human 269 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315228 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315228&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426888 383541989 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612157 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1cc(F)c(cc1F)-c1cncc(c1)C(F)(F)F InChI=1S/C29H27F5N2O3/c1-16-17(9-10-26(37)38)7-4-8-25(16)36-28(39)27(18-5-2-3-6-18)22-13-23(30)21(12-24(22)31)19-11-20(15-35-14-19)29(32,33)34/h4,7-8,11-15,18,27H,2-3,5-6,9-10H2,1H3,(H,36,39)(H,37,38) WPRGAIHLZUKXPP-UHFFFAOYSA-N 315229 (R/S) 3-{3-[(cyclopentyl{2,5-difluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 179 Prostaglandin G/H synthase 2 Human 85.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315229 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315229&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417214 383541990 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612158 Cc1ncc(cc1Cl)-c1cc(F)c(cc1F)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H29ClF2N2O3/c1-16-18(10-11-27(35)36)8-5-9-26(16)34-29(37)28(19-6-3-4-7-19)22-14-24(31)21(13-25(22)32)20-12-23(30)17(2)33-15-20/h5,8-9,12-15,19,28H,3-4,6-7,10-11H2,1-2H3,(H,34,37)(H,35,36) SCYNQYGLWFZKDW-UHFFFAOYSA-N 315230 (R/S) 3-[3-({[4-(5-chloro-6-methylpyridin-3-yl)-2,5-difluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 180 Prostaglandin G/H synthase 2 Human 66.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315230 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315230&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426972 383541991 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612159 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(F)cc1-c1cncc(Cl)c1 InChI=1S/C29H30ClFN2O3/c1-17-12-24(25(31)14-23(17)21-13-22(30)16-32-15-21)28(20-6-3-4-7-20)29(36)33-26-9-5-8-19(18(26)2)10-11-27(34)35/h5,8-9,12-16,20,28H,3-4,6-7,10-11H2,1-2H3,(H,33,36)(H,34,35) FRZXOYSEVZVKOX-UHFFFAOYSA-N 315231 (R/S) 3-[3-({[4-(5-chloropyridin-3-yl)-2-fluoro-5-methylphenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 181 Prostaglandin G/H synthase 2 Human 2300 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315231 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315231&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426929 383541992 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612160 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(F)cc1-c1cnc(C)c(Cl)c1 InChI=1S/C30H32ClFN2O3/c1-17-13-24(26(32)15-23(17)22-14-25(31)19(3)33-16-22)29(21-7-4-5-8-21)30(37)34-27-10-6-9-20(18(27)2)11-12-28(35)36/h6,9-10,13-16,21,29H,4-5,7-8,11-12H2,1-3H3,(H,34,37)(H,35,36) LNJWJLARXOLAKQ-UHFFFAOYSA-N 315232 (R/S) 3-[3-({[4-(5-chloro-6-methylpyridin-3-yl)-2-fluoro-5-methylphenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 182 Prostaglandin G/H synthase 2 Human 741 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315232 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315232&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426932 383541993 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612161 Cc1cc(C(C2CCCC2)C(=O)Nc2cccc(CCC(O)=O)c2C)c(F)cc1-c1cncc(c1)C(F)(F)F InChI=1S/C30H30F4N2O3/c1-17-12-24(25(31)14-23(17)21-13-22(16-35-15-21)30(32,33)34)28(20-6-3-4-7-20)29(39)36-26-9-5-8-19(18(26)2)10-11-27(37)38/h5,8-9,12-16,20,28H,3-4,6-7,10-11H2,1-2H3,(H,36,39)(H,37,38) NUBWFZSIZCXUPS-UHFFFAOYSA-N 315233 (R/S) 3-{3-[(cyclopentyl{2-fluoro-5-methyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 183 Prostaglandin G/H synthase 2 Human 1000 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315233&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426870 383541994 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612162 Cc1ncc(cc1Cl)-c1ccc(cc1)[C@@H](C1CCCC1)C(=O)Nc1ccc(F)c(CCC(O)=O)c1C |r| InChI=1S/C29H30ClFN2O3/c1-17-23(11-14-27(34)35)25(31)12-13-26(17)33-29(36)28(20-5-3-4-6-20)21-9-7-19(8-10-21)22-15-24(30)18(2)32-16-22/h7-10,12-13,15-16,20,28H,3-6,11,14H2,1-2H3,(H,33,36)(H,34,35) LAIGNYKUKZIXAV-UHFFFAOYSA-N 315234 3-[3-({(2R)-2-[4-(5-chloro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-6-fluoro-2-methylphenyl]propanoic acid::US10172814, Example 184 Prostaglandin G/H synthase 2 Human 23.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315234 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315234&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417153 383541995 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612163 Cc1c(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)ccc(F)c1CCC(O)=O |r| InChI=1S/C28H28ClFN2O3/c1-17-23(10-13-26(33)34)24(30)11-12-25(17)32-28(35)27(19-4-2-3-5-19)20-8-6-18(7-9-20)21-14-22(29)16-31-15-21/h6-9,11-12,14-16,19,27H,2-5,10,13H2,1H3,(H,32,35)(H,33,34) QKEDBNBCEXEBSG-UHFFFAOYSA-N 315235 3-[3-({(2R)-2-[4-(5-chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-6-fluoro-2-methylphenyl]propanoic acid::US10172814, Example 185 Prostaglandin G/H synthase 2 Human 69.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315235&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416998 383541996 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612164 CN(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C |r| InChI=1S/C28H30ClN3O3/c1-18-24(8-5-9-25(18)32(2)17-26(33)34)31-28(35)27(20-6-3-4-7-20)21-12-10-19(11-13-21)22-14-23(29)16-30-15-22/h5,8-16,20,27H,3-4,6-7,17H2,1-2H3,(H,31,35)(H,33,34) SRDXRPFGRDRORW-UHFFFAOYSA-N 315236 N-[3-({(2R)-2-[4-(5-chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-N-methylglycine::US10172814, Example 186 Prostaglandin G/H synthase 2 Human 43.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315236 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315236&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416985 383541997 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612165 CN(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cnc(C)c(Cl)c2)c1C |r| InChI=1S/C29H32ClN3O3/c1-18-25(9-6-10-26(18)33(3)17-27(34)35)32-29(36)28(21-7-4-5-8-21)22-13-11-20(12-14-22)23-15-24(30)19(2)31-16-23/h6,9-16,21,28H,4-5,7-8,17H2,1-3H3,(H,32,36)(H,34,35) ZMVLYDKEZITCJX-UHFFFAOYSA-N 315237 N-[3-({(2R)-2-[4-(5-chloro-6-methylpyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-N-methylglycine::US10172814, Example 187 Prostaglandin G/H synthase 2 Human 23.9 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315237 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315237&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417068 383541998 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612166 CN(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(c2)C(F)(F)F)c1C InChI=1S/C29H29F4N3O3/c1-17-24(8-5-9-25(17)36(2)16-26(37)38)35-28(39)27(18-6-3-4-7-18)19-10-11-22(23(30)13-19)20-12-21(15-34-14-20)29(31,32)33/h5,8-15,18,27H,3-4,6-7,16H2,1-2H3,(H,35,39)(H,37,38) VBUFQONABLGIBX-UHFFFAOYSA-N 315238 (−) N-{3-[(cyclopentyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}-N-methylglycine, Single Enantiomer::US10172814, Example 188 Prostaglandin G/H synthase 2 Human 24.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315238 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315238&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417037 383541999 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612167 CC(C)Cc1cncc(c1)-c1ccc(cc1)[C@@H](C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C |r| InChI=1S/C32H38N2O3/c1-21(2)17-23-18-28(20-33-19-23)25-11-13-27(14-12-25)31(26-7-4-5-8-26)32(37)34-29-10-6-9-24(22(29)3)15-16-30(35)36/h6,9-14,18-21,26,31H,4-5,7-8,15-17H2,1-3H3,(H,34,37)(H,35,36) STCYPKHHZKEGMK-UHFFFAOYSA-N 315239 3-(3-{[(2R)-2-cyclopentyl-2-{4-[5-(2-methylpropyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 189 Prostaglandin G/H synthase 2 Human 15.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315239 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315239&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417115 383542000 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612168 CC(C)Oc1cncc(c1)-c1ccc(cc1)[C@@H](C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C |r| InChI=1S/C31H36N2O4/c1-20(2)37-27-17-26(18-32-19-27)23-11-13-25(14-12-23)30(24-7-4-5-8-24)31(36)33-28-10-6-9-22(21(28)3)15-16-29(34)35/h6,9-14,17-20,24,30H,4-5,7-8,15-16H2,1-3H3,(H,33,36)(H,34,35) YBOFONPCAOMXPE-UHFFFAOYSA-N 315240 3-(3-{[(2R)-2-cyclopentyl-2-{4-[5-(propan-2-yloxy)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 190 Prostaglandin G/H synthase 2 Human 36.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315240 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315240&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417060 383542001 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612169 Cc1c(CCC(O)=O)cccc1NC(=O)[C@H](C1CCCC1)c1ccc(cc1)-c1cncc(CC(F)(F)F)c1 |r| InChI=1S/C30H31F3N2O3/c1-19-21(13-14-27(36)37)7-4-8-26(19)35-29(38)28(23-5-2-3-6-23)24-11-9-22(10-12-24)25-15-20(17-34-18-25)16-30(31,32)33/h4,7-12,15,17-18,23,28H,2-3,5-6,13-14,16H2,1H3,(H,35,38)(H,36,37) YJSRDKHRWVOMER-UHFFFAOYSA-N 315241 3-(3-{[(2R)-2-cyclopentyl-2-{4-[5-(2,2,2-trifluoroethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 191 Prostaglandin G/H synthase 2 Human 60.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315241 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315241&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417159 383542002 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612170 Cc1ncc(cc1C(F)(F)F)-c1ccc(cc1)[C@@H](C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C |r| InChI=1S/C30H31F3N2O3/c1-18-20(14-15-27(36)37)8-5-9-26(18)35-29(38)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(30(31,32)33)19(2)34-17-24/h5,8-13,16-17,22,28H,3-4,6-7,14-15H2,1-2H3,(H,35,38)(H,36,37) YILCZFTZYAVJRF-UHFFFAOYSA-N 315242 3-(3-{[(2R)-2-cyclopentyl-2-{4-[6-methyl-5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)propanoic acid::US10172814, Example 192 Prostaglandin G/H synthase 2 Human 13.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315242 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315242&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417163 383542003 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612171 Cc1c(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)cccc1C(O)CC(O)=O |r| InChI=1S/C28H29ClN2O4/c1-17-23(25(32)14-26(33)34)7-4-8-24(17)31-28(35)27(19-5-2-3-6-19)20-11-9-18(10-12-20)21-13-22(29)16-30-15-21/h4,7-13,15-16,19,25,27,32H,2-3,5-6,14H2,1H3,(H,31,35)(H,33,34) WNXNKULAIMFMJO-UHFFFAOYSA-N 315243 3-[3-({(2R)-2-[4-(5-chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]-3-hydroxypropanoic acid::US10172814, Example 193 Prostaglandin G/H synthase 2 Human 232 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315243 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315243&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417209 383542004 C03834 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612172 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(CC(C)C)c2)c1C InChI=1S/C34H41FN2O3/c1-5-24(18-32(38)39)28-11-8-12-31(22(28)4)37-34(40)33(25-9-6-7-10-25)26-13-14-29(30(35)17-26)27-16-23(15-21(2)3)19-36-20-27/h8,11-14,16-17,19-21,24-25,33H,5-7,9-10,15,18H2,1-4H3,(H,37,40)(H,38,39) PTZJTFCAMUHYHR-UHFFFAOYSA-N 315244 3-[3-({cyclopentyl[3-fluoro-4-(5-isobutylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid, single enantiomer::US10172814, Example 194 Prostaglandin G/H synthase 2 Human 6.82 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315244&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417193 383542005 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612173 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cncc(CC)c2)c1C InChI=1S/C32H37FN2O3/c1-4-21-15-25(19-34-18-21)27-14-13-24(16-28(27)33)31(23-9-6-7-10-23)32(38)35-29-12-8-11-26(20(29)3)22(5-2)17-30(36)37/h8,11-16,18-19,22-23,31H,4-7,9-10,17H2,1-3H3,(H,35,38)(H,36,37) HYXRWYXNVCRQDD-UHFFFAOYSA-N 315245 3-[3-({cyclopentyl[4-(5-ethylpyridin-3-yl)-3-fluorophenyl]acetyl}amino)-2-methylphenyl]pentanoic acid, Single Enantiomer::US10172814, Example 195 Prostaglandin G/H synthase 2 Human 10.5 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315245 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315245&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416991 383542006 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612174 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(CC(F)(F)F)c1 InChI=1S/C30H30F4N2O3/c1-18-20(10-12-27(37)38)7-4-8-26(18)36-29(39)28(21-5-2-3-6-21)22-9-11-24(25(31)14-22)23-13-19(16-35-17-23)15-30(32,33)34/h4,7-9,11,13-14,16-17,21,28H,2-3,5-6,10,12,15H2,1H3,(H,36,39)(H,37,38) WTUZQDUHEMORQJ-UHFFFAOYSA-N 315246 (−) 3-{3-[(cyclopentyl{3-fluoro-4-[5-(2,2,2-trifluoroethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid, Single Enantiomer::US10172814, Example 196 Prostaglandin G/H synthase 2 Human 74.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315246 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315246&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417227 383542007 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612175 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cnc(F)c(c1)C(F)(F)F InChI=1S/C29H27F5N2O3/c1-16-17(10-12-25(37)38)7-4-8-24(16)36-28(39)26(18-5-2-3-6-18)19-9-11-21(23(30)14-19)20-13-22(29(32,33)34)27(31)35-15-20/h4,7-9,11,13-15,18,26H,2-3,5-6,10,12H2,1H3,(H,36,39)(H,37,38) IAQRXESEEPXFHB-UHFFFAOYSA-N 315247 (−) 3-{3-[(cyclopentyl{3-fluoro-4-[6-methyl-5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid, Single Enantiomer::US10172814, Example 197 Prostaglandin G/H synthase 2 Human 19.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315247 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315247&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 132217703 383542008 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612176 CC(C)Cc1cc(cnc1C)-c1ccc(cc1F)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C33H39FN2O3/c1-20(2)16-26-17-27(19-35-22(26)4)28-14-12-25(18-29(28)34)32(24-8-5-6-9-24)33(39)36-30-11-7-10-23(21(30)3)13-15-31(37)38/h7,10-12,14,17-20,24,32H,5-6,8-9,13,15-16H2,1-4H3,(H,36,39)(H,37,38) JDPNUYJWAFSVKW-UHFFFAOYSA-N 315248 (−) 3-[3-({cyclopentyl[3-fluoro-4-(5-isobutyl-6-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid, Single Enantiomer::US10172814, Example 198 Prostaglandin G/H synthase 2 Human 20.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315248&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417288 383542009 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612177 CC(C)Oc1cncc(c1)-c1ccc(cc1F)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C31H35FN2O4/c1-19(2)38-25-15-24(17-33-18-25)26-13-11-23(16-27(26)32)30(22-7-4-5-8-22)31(37)34-28-10-6-9-21(20(28)3)12-14-29(35)36/h6,9-11,13,15-19,22,30H,4-5,7-8,12,14H2,1-3H3,(H,34,37)(H,35,36) ZFGDWLLTWNEVMB-UHFFFAOYSA-N 315249 (−) 3-[3-({cyclopentyl[3-fluoro-4-(5-isopropoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid, Single Enantiomer::US10172814, Example 199 Prostaglandin G/H synthase 2 Human 30.2 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315249&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417187 383542010 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612178 CCC(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(CC(F)(F)F)c2)c1C |r| InChI=1S/C32H35F3N2O3/c1-3-22(16-29(38)39)27-9-6-10-28(20(27)2)37-31(40)30(24-7-4-5-8-24)25-13-11-23(12-14-25)26-15-21(18-36-19-26)17-32(33,34)35/h6,9-15,18-19,22,24,30H,3-5,7-8,16-17H2,1-2H3,(H,37,40)(H,38,39) YOSHOKIEDPKMGI-UHFFFAOYSA-N 315250 3-(3-{[(2R)-2-cyclopentyl-2-{4-[5-(2,2,2-trifluoroethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)pentanoic acid, Single Enantiomer::US10172814, Example 200 Prostaglandin G/H synthase 2 Human 17.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315250&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417003 383542011 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612179 CCC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(c(F)c2)-c2cnc(C)c(c2)C(F)(F)F)c1C InChI=1S/C32H34F4N2O3/c1-4-20(16-29(39)40)24-10-7-11-28(18(24)2)38-31(41)30(21-8-5-6-9-21)22-12-13-25(27(33)15-22)23-14-26(32(34,35)36)19(3)37-17-23/h7,10-15,17,20-21,30H,4-6,8-9,16H2,1-3H3,(H,38,41)(H,39,40) QWEKIHNVBWZXDA-UHFFFAOYSA-N 315251 3-(3-{[(2R)-2-cyclopentyl-2-{4-[6-methyl-5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-methylphenyl)pentanoic acid, Single Enantiomer::US10172814, Example 201 Prostaglandin G/H synthase 2 Human 6.57 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315251&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 137395103 383542012 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612180 CCC(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(CC(C)C)c2)c1C |r| InChI=1S/C34H42N2O3/c1-5-25(19-32(37)38)30-11-8-12-31(23(30)4)36-34(39)33(27-9-6-7-10-27)28-15-13-26(14-16-28)29-18-24(17-22(2)3)20-35-21-29/h8,11-16,18,20-22,25,27,33H,5-7,9-10,17,19H2,1-4H3,(H,36,39)(H,37,38) OYYPUWHVMWNOPI-UHFFFAOYSA-N 315252 3-[3-({(2R)-2-cyclopentyl-2-[4-(5-isobutylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid, Single Enantiomer::US10172814, Example 202 Prostaglandin G/H synthase 2 Human 10.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315252&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417166 383542013 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612181 CCC(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(OC(C)C)c2)c1C |r| InChI=1S/C33H40N2O4/c1-5-23(18-31(36)37)29-11-8-12-30(22(29)4)35-33(38)32(25-9-6-7-10-25)26-15-13-24(14-16-26)27-17-28(20-34-19-27)39-21(2)3/h8,11-17,19-21,23,25,32H,5-7,9-10,18H2,1-4H3,(H,35,38)(H,36,37) CRLITSSANWJYLP-UHFFFAOYSA-N 315253 3-[3-({(2R)-2-cyclopentyl-2-[4-(5-isopropoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid, Single Enantiomer::US10172814, Example 203 Prostaglandin G/H synthase 2 Human 16.7 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315253 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315253&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417133 383542014 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612182 CCC(CC(O)=O)c1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(CC)c2)c1C |r| InChI=1S/C32H38N2O3/c1-4-22-17-27(20-33-19-22)24-13-15-26(16-14-24)31(25-9-6-7-10-25)32(37)34-29-12-8-11-28(21(29)3)23(5-2)18-30(35)36/h8,11-17,19-20,23,25,31H,4-7,9-10,18H2,1-3H3,(H,34,37)(H,35,36) YCZXGDRTZAULOW-UHFFFAOYSA-N 315254 3-[3-({(2R)-2-cyclopentyl-2-[4-(5-ethylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]pentanoic acid, Single Enantiomer::US10172814, Example 204 Prostaglandin G/H synthase 2 Human 20.8 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315254 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315254&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417046 383542015 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612183 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(c(F)c1)-c1cncc(CC(F)(F)F)c1 InChI=1S/C29H28F4N2O3/c1-17-19(9-11-26(36)37)4-3-7-25(17)35-28(38)27(20-5-2-6-20)21-8-10-23(24(30)13-21)22-12-18(15-34-16-22)14-29(31,32)33/h3-4,7-8,10,12-13,15-16,20,27H,2,5-6,9,11,14H2,1H3,(H,35,38)(H,36,37) JZRRGLTYMVJZJT-UHFFFAOYSA-N 315255 3-{3-[(cyclobutyl{3-fluoro-4-[5-(2,2,2-trifluoroethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid, Single Enantiomer::US10172814, Example 205 Prostaglandin G/H synthase 2 Human 66.4 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315255&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417158 383542016 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612184 Cc1ncc(cc1C(F)(F)F)-c1ccc(cc1F)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H28F4N2O3/c1-16-18(10-12-26(36)37)5-4-8-25(16)35-28(38)27(19-6-3-7-19)20-9-11-22(24(30)14-20)21-13-23(29(31,32)33)17(2)34-15-21/h4-5,8-9,11,13-15,19,27H,3,6-7,10,12H2,1-2H3,(H,35,38)(H,36,37) SNJVXEVRMWGISW-UHFFFAOYSA-N 315256 (−) 3-{3-[(cyclobutyl{3-fluoro-4-[6-methyl-5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid, Single Enantiomer::US10172814, Example 206 Prostaglandin G/H synthase 2 Human 10.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315256&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417031 383542017 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612185 CC(C)Cc1cncc(c1)-c1ccc(cc1F)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C31H35FN2O3/c1-19(2)14-21-15-25(18-33-17-21)26-12-10-24(16-27(26)32)30(23-7-4-8-23)31(37)34-28-9-5-6-22(20(28)3)11-13-29(35)36/h5-6,9-10,12,15-19,23,30H,4,7-8,11,13-14H2,1-3H3,(H,34,37)(H,35,36) CBQWOUFQYNLUTC-UHFFFAOYSA-N 315257 3-[3-({cyclobutyl[3-fluoro-4-(5-isobutylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid, Single Enantiomer::US10172814, Example 207 Prostaglandin G/H synthase 2 Human 14.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315257&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416996 383542018 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612186 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H26F4N2O3/c1-16-17(9-11-25(35)36)4-3-7-24(16)34-27(37)26(18-5-2-6-18)19-8-10-22(23(29)13-19)20-12-21(15-33-14-20)28(30,31)32/h3-4,7-8,10,12-15,18,26H,2,5-6,9,11H2,1H3,(H,34,37)(H,35,36) FJXHGDUMEUOBOT-UHFFFAOYSA-N 315258 (−) 3-{3-[(cyclobutyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid, Single Enantiomer::US10172814, Example 208 Prostaglandin G/H synthase 2 Human 28.1 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315258&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417015 383542019 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612187 CC(C)Oc1cncc(c1)-c1ccc(cc1F)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C30H33FN2O4/c1-18(2)37-24-14-23(16-32-17-24)25-12-10-22(15-26(25)31)29(21-7-4-8-21)30(36)33-27-9-5-6-20(19(27)3)11-13-28(34)35/h5-6,9-10,12,14-18,21,29H,4,7-8,11,13H2,1-3H3,(H,33,36)(H,34,35) YWNMUTDKQGUXKF-UHFFFAOYSA-N 315259 (−) 3-[3-({cyclobutyl[3-fluoro-4-(5-isopropoxypyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid, Single Enantiomer::US10172814, Example 209 Prostaglandin G/H synthase 2 Human 39.3 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315259 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315259&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417212 383542020 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612188 CCc1cncc(c1)-c1ccc(cc1F)C(C1CCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H31FN2O3/c1-3-19-14-23(17-31-16-19)24-12-10-22(15-25(24)30)28(21-7-4-8-21)29(35)32-26-9-5-6-20(18(26)2)11-13-27(33)34/h5-6,9-10,12,14-17,21,28H,3-4,7-8,11,13H2,1-2H3,(H,32,35)(H,33,34) DCDIYRZMEGSVCN-UHFFFAOYSA-N 315260 (−) 3-[3-({cyclobutyl[4-(5-ethylpyridin-3-yl)-3-fluorophenyl]acetyl}amino)-2-methylphenyl]propanoic acid, Single Enantiomer::US10172814, Example 210 Prostaglandin G/H synthase 2 Human 35.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315260&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417071 383542021 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612189 Cc1ncc(cc1F)-c1ccc(cc1)C(C1CCCC1)C(=O)Nc1cccc(CCC(O)=O)c1C InChI=1S/C29H31FN2O3/c1-18-20(14-15-27(33)34)8-5-9-26(18)32-29(35)28(22-6-3-4-7-22)23-12-10-21(11-13-23)24-16-25(30)19(2)31-17-24/h5,8-13,16-17,22,28H,3-4,6-7,14-15H2,1-2H3,(H,32,35)(H,33,34) XCNZUZBAHRAXON-UHFFFAOYSA-N 315261 (R/S) 3-[3-({cyclopentyl[4-(5-fluoro-6-methylpyridin-3-yl)phenyl]acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 211 Prostaglandin G/H synthase 2 Human 190 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315261&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121426976 383542022 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612190 COc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(Cl)c1 InChI=1S/C28H29ClN2O4/c1-35-27-21(13-14-25(32)33)7-4-8-24(27)31-28(34)26(19-5-2-3-6-19)20-11-9-18(10-12-20)22-15-23(29)17-30-16-22/h4,7-12,15-17,19,26H,2-3,5-6,13-14H2,1H3,(H,31,34)(H,32,33) OYJBFVTYWPIZAE-UHFFFAOYSA-N 315262 3-[3-({[4-(5-chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methoxyphenyl]propanoic acid::US10172814, Example 212 Prostaglandin G/H synthase 2 Human 569 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315262 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315262&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417161 383542023 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612191 COc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H29F3N2O4/c1-38-27-21(13-14-25(35)36)7-4-8-24(27)34-28(37)26(19-5-2-3-6-19)20-11-9-18(10-12-20)22-15-23(17-33-16-22)29(30,31)32/h4,7-12,15-17,19,26H,2-3,5-6,13-14H2,1H3,(H,34,37)(H,35,36) VOMGDCNFRVOGRU-UHFFFAOYSA-N 315263 3-{3-[(cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methoxyphenyl}propanoic acid::US10172814, Example 213 Prostaglandin G/H synthase 2 Human 328 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315263&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417047 383542024 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612192 OC(=O)CCc1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C(F)(F)F |r| InChI=1S/C28H26ClF3N2O3/c29-22-14-21(15-33-16-22)17-8-10-19(11-9-17)25(18-4-1-2-5-18)27(37)34-23-7-3-6-20(12-13-24(35)36)26(23)28(30,31)32/h3,6-11,14-16,18,25H,1-2,4-5,12-13H2,(H,34,37)(H,35,36) PLPTWKQUOJUOPK-UHFFFAOYSA-N 315264 3-[3-({(2R)-2-[4-(5-chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-(trifluoromethyl)phenyl]propanoic acid::US10172814, Example 214 Prostaglandin G/H synthase 2 Human 381 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315264&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416987 383542025 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612193 OC(=O)CCc1cccc(NC(=O)[C@H](C2CCCC2)c2ccc(cc2)-c2cncc(c2)C(F)(F)F)c1C(F)(F)F |r| InChI=1S/C29H26F6N2O3/c30-28(31,32)22-14-21(15-36-16-22)17-8-10-19(11-9-17)25(18-4-1-2-5-18)27(40)37-23-7-3-6-20(12-13-24(38)39)26(23)29(33,34)35/h3,6-11,14-16,18,25H,1-2,4-5,12-13H2,(H,37,40)(H,38,39) VGPRCMVBWQOMKV-UHFFFAOYSA-N 315265 3-[3-{[(2R)-2-cyclopentyl-2-{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl]amino}-2-(trifluoromethyl)phenyl]propanoic acid::US10172814, Example 215 Prostaglandin G/H synthase 2 Human 258 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315265&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417028 383542026 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612194 Cc1c(CCC(O)=O)cccc1NC(=O)[C@H](C1CCCC1)c1ccc(cc1)-c1cncc(Cl)c1 |r| InChI=1S/C28H29ClN2O3/c1-18-19(13-14-26(32)33)7-4-8-25(18)31-28(34)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(29)17-30-16-23/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,31,34)(H,32,33) LUWOXMQWGOWQSN-UHFFFAOYSA-N 314833 (−) (R) 3-[3-({[4-(5-Chloropyridin-3-yl)phenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 17 Prostaglandin G/H synthase 2 Human 35.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314833 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314833&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417226 383541655 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612195 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(Cl)c1 InChI=1S/C28H28ClFN2O3/c1-17-18(10-12-26(33)34)7-4-8-25(17)32-28(35)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(29)16-31-15-21/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,32,35)(H,33,34) OZUBHMWSFYBJDO-UHFFFAOYSA-N 314867 (−) 3-[3-({[4-(5-Chloropyridin-3-yl)-3-fluorophenyl](cyclopentyl)acetyl}amino)-2-methylphenyl]propanoic acid::US10172814, Example 44 Prostaglandin G/H synthase 2 Human 18.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314867&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417061 383541686 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612196 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F InChI=1S/C28H27F3N2O3/c1-17-18(12-13-25(34)35)4-3-7-24(17)33-27(36)26(20-5-2-6-20)21-10-8-19(9-11-21)22-14-23(16-32-15-22)28(29,30)31/h3-4,7-11,14-16,20,26H,2,5-6,12-13H2,1H3,(H,33,36)(H,34,35) VNSSZYUUZGLDIH-UHFFFAOYSA-N 314879 (−) 3-{3-[(Cyclobutyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 55 Prostaglandin G/H synthase 2 Human 27.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314879 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314879&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417165 383541698 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612197 CC(CC(O)=O)c1cccc(NC(=O)C(C2CCCC2)c2ccc(cc2)-c2cncc(Cl)c2)c1C InChI=1S/C29H31ClN2O3/c1-18(14-27(33)34)25-8-5-9-26(19(25)2)32-29(35)28(21-6-3-4-7-21)22-12-10-20(11-13-22)23-15-24(30)17-31-16-23/h5,8-13,15-18,21,28H,3-4,6-7,14H2,1-2H3,(H,32,35)(H,33,34) ZMPUWAPOGIXWRT-UHFFFAOYSA-N 315143 US10172814, Example 88::(3R/S)-3-[3-({(2R/S)-2-[4-(5-Chloropyridin-3-yl)phenyl]-2-cyclopentylacetyl}amino)-2-methylphenyl]butanoic acid::US10172814, Example 89::US10172814, Example 86::US10172814, Example 87::US10172814, Example 85 Prostaglandin G/H synthase 2 Human 8.00 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=315143 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=315143&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417263 383541943 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612198 Cc1c(CCC(O)=O)cccc1NC(=O)C(C1CCCC1)c1ccc(c(F)c1)-c1cncc(c1)C(F)(F)F InChI=1S/C29H28F4N2O3/c1-17-18(10-12-26(36)37)7-4-8-25(17)35-28(38)27(19-5-2-3-6-19)20-9-11-23(24(30)14-20)21-13-22(16-34-15-21)29(31,32)33/h4,7-9,11,13-16,19,27H,2-3,5-6,10,12H2,1H3,(H,35,38)(H,36,37) JAWBAVZNIXODOD-UHFFFAOYSA-N 314872 (−) 3-{3-[(Cyclopentyl{3-fluoro-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 48 Prostaglandin G/H synthase 2 Human 3.00 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314872 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314872&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121417117 383541691 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876 612199 Cc1c(CCC(O)=O)cccc1NC(=O)[C@H](C1CCCC1)c1ccc(cc1)-c1cncc(c1)C(F)(F)F |r| InChI=1S/C29H29F3N2O3/c1-18-19(13-14-26(35)36)7-4-8-25(18)34-28(37)27(21-5-2-3-6-21)22-11-9-20(10-12-22)23-15-24(17-33-16-23)29(30,31)32/h4,7-12,15-17,21,27H,2-3,5-6,13-14H2,1H3,(H,34,37)(H,35,36) BQUFVNCYDJQTBE-UHFFFAOYSA-N 314817 (−) (R) 3-{3-[(Cyclopentyl{4-[5-(trifluoromethyl)pyridin-3-yl]phenyl}acetyl)amino]-2-methylphenyl}propanoic acid::US10172814, Example 2 Prostaglandin G/H synthase 2 Human 21.0 US Patent 10.7270/Q20K2BNW aid1796509 US10172814 Brauer, N; Nagel, J; Irlbacher, H; Rotgeri, A; Schwede, W; Dahllof, H; Koppitz, M; Peters, M; Godinho-Coelho, A 1/8/2019 4/30/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=314817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2262&target=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=314817&enzyme=Prostaglandin+G%2FH+synthase+2&column=ki&startPg=0&Increment=50&submit=Search 121416986 383541640 1 MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL 5F1A,5IKV,5IKT,5IKR,5IKQ,5F19,3MDL,4PH9 Prostaglandin G/H synthase 2 PGH2_HUMAN P35354 A8K802 Q16876